Angina

Angina pectoris is a manifestation of ischaemia of the heart muscle usually caused by diseased coronary arteries. Stable angina occurs when the frequency, severity, duration, time of appearance and precipitating factors for the angina remain unchanged for 60 days.82 It is by far the most common form of angina and symptoms typically develop with a defined amount of exercise and abate after a short period of rest. As well as physical activity, stable angina can be precipitated by emotion, eating or cold weather. Angina can also result from an acute reduction in coronary blood flow, and this type of angina can occur at rest. This may result from transient restriction of the flow in the coronary arteries by platelets or a thrombus, or by physiological or pathological vasoconstriction. Vasoconstriction of a normal or minimally diseased coronary artery is referred to as variant or Prinzmetal angina and is now considered to be rare.83 Unstable angina describes a spectrum of ischaemic events somewhere between stable angina and myocardial infarction (heart attack). An estimated 5% of unstable angina patients die within the first few months of diagnosis.84

Stable angina is mostly a distressing rather than dangerous symptom, but there is an increased risk of heart attack and a small proportion will have fatal or serious attacks soon after diagnosis. It is therefore not a condition to be treated casually. Conventional prescription drugs may be necessary, although these most often work well with herbal treatments. Reduction in smoking, hypertension, obesity, any high cholesterol or lipidaemia and a measured increase in exercise is strongly advisable if these measures can be introduced without serious perturbation.

Treatment

The key herb is Crataegus (hawthorn). Preparations from the leaves and flowers and/or berries may be used. As well as being proven in clinical trials to reduce myocardial oxygen demand (see the hawthorn monograph), Crataegus is antioxidant, cardioprotective and a coronary artery vasodilator. Clinical trials have shown that Crataegus is safe to combine with conventional drugs. In patients with ischaemic heart disease, Crataegus decreased the signs of ischaemia as assessed by an exercise ECG test.85 A related species of Crataegus has been successfully trialled for angina in China in an open label study.86

The key Ayurvedic herbs Terminalia arjuna and Inula racemosa (a close relative of elecampane – Inula helenium) have been shown to benefit angina in clinical trials.87

Ginkgo (by injection) has improved coronary blood flow in patients with coronary artery disease and favourably affects some cardiovascular risk factors (see Ginkgo monograph).

Salvia miltiorrhiza (dan shen) is a Chinese herb clinically studied for angina and other heart conditions.88 Its benefits include cardioprotective, vasodilator and antiplatelet activities. Astragalus can also be of potential value (see Astragalus monograph). There is evidence from a clinical trial that Korean red ginseng improved coronary flow reserve in post-myocardial infarction patients.89

Antiplatelet herbs such as Coleus forskohlii, Allium sativum (garlic), Zingiber (ginger) and Curcuma longa (turmeric) may have value even if the patient is taking antiplatelet medication, because of their differing mechanisms of action. (They do not appear to decrease prostacyclin production.) They also have other properties that may be beneficial; for example, Coleus is a vasodilator and Curcuma is antioxidant. However, care should be taken to ensure that bleeding time is not excessively prolonged. (See the ginger and turmeric monographs.)

Capsicum spp. (cayenne) has fibrinolytic activity and was traditionally used to improve myocardial blood supply.

Vasodilating and relaxing herbs have been traditionally prescribed for angina and include Tilia species (lime flowers) and Viburnum opulus (cramp bark). In cases of stable angina they are probably of little value since they would be unlikely to widen a diseased artery restricted by atheroma. However, they might be considered for angina exacerbated by stress and anxiety, together with Valeriana and Corydalis or similar calming herbs.

Example liquid formula

An example formula for stable angina is provided below:

Crataegus folia 1:2 50 mL
Zingiber officinale 1:2 10 mL
Salvia miltiorrhiza 1:2 40 mL
    100 mL

Dose: 8 mL with water twice times daily.

Allicin-releasing garlic tablets (equivalent to about 6 to 12 g/day of fresh garlic and providing at least 12 mg/day alliin).

Hyperlipidaemia and cardiovascular risk factors

Atherogenesis is no longer considered a disorder of lipid accumulation, but a disease process characterised by a dynamic interaction between endothelial (vessel lining) dysfunction, subendothelial inflammation and a ‘wound healing’ response of the vascular smooth muscle cells. Oxidation of LDL (low-density lipoprotein) triggers the recruitment of macrophages into the arterial wall. They accumulate cholesterol, becoming foam cells.90,91

The American Heart Association Prevention Conference in 1999 classified cardiovascular risk factors into three categories. The traditional or conventional risk factors came from the Framingham Heart Study and are thought to have a direct causal role in atherogenesis.90 Predisposing factors may act through the conventional factors, but may also have independent effects. Conditional risk factors are associated with increased risk of ischaemic heart disease, although their causative and/or independent contributions are still debated. They may further enhance risk if traditional factors are present, hence the term ‘conditional’.90 A fourth category can be added of the emerging risk factors still under preliminary study.

The conventional risk factors comprise cigarette smoking, elevated blood pressure, elevated total or LDL serum cholesterol, low HDL-cholesterol and diabetes mellitus.

Predisposing risk factors are high BMI, visceral adiposity, physical inactivity, male sex, family history of early onset coronary disease, socioeconomic and behavioural factors (e.g. type A personality) and insulin resistance (sometimes regarded as a conditional factor).

Conditional risk factors are currently defined as elevated homocysteine, elevated fibrinogen, elevated lipoprotein(a), small dense LDL particles, elevated C-reactive protein (CRP) and elevated triglycerides.

Emerging risk factors include vascular calcification, infection and periodontal disease, elevated gamma-glutamyltransferase (GGT), low heart rate variability and low red blood cell omega-3 fatty acids (omega-3 index). Some emerging factors are naturally quite controversial.

Hyperlipidaemia may involve hypercholesterolaemia (elevated serum cholesterol) or hypertriglyceridaemia (evaluated serum triglycerides). In adults less than 65 years of age, a total cholesterol concentration greater than 6 mmol/L (240 mg/dL) or a triglyceride concentration greater than 2.8 mmol/L (250 mg/dL) clearly indicates hyperlipidaemia. However, in the presence of other independent risk factors for atherosclerosis, levels lower than these may require treatment (a ‘desirable’ cholesterol level is less than 5.2 mmol/L). Low HDL-cholesterol, below 0.9 mmol/L (35 mg/dL), is also a risk factor for atherosclerosis, as is a high LDL-cholesterol (with a target often of 2.5 mmol/L or less).

While there is no doubt that hyperlipidaemia, especially hypercholesterolaemia, is associated with increased incidence of premature ischaemic heart disease,92 intervention with drug therapy, especially in some populations, has been controversial, as for example in healthy women93 and the elderly (where high cholesterol levels may even be protective of health94). However, the benefits of treating raised cholesterol in most patients with CHD after a myocardial infarction (secondary prevention) are clear.95

There is certainly a clear consensus in the mainstream literature that LDL-cholesterol is a significant cardiovascular risk factor. However, the predictive value of future cardiovascular events of LDL-cholesterol appears limited.96 LDL-cholesterol is a more complex issue than previously realised; the subfraction of intermediate density lipoprotein (IDL) cholesterol might be the true atherogenic factor and the number of LDL particles is also important.96 HDL-cholesterol is a more sensitive predictor of cardiovascular risk and levels are predictive of major cardiovascular events in patients treated with statins, even those with target LDL-cholesterol.96 Overall, the correlation between HDL-cholesterol and the incidence of CHD is better than for LDL-cholesterol. This holds true for all LDL levels, independent of statin drug treatment.96 Triglyceride levels are acknowledged by many experts now as an independent risk factor (that is, are not conditional on LDL-cholesterol or HDL-cholesterol levels) and non-fasting levels (VLDL plus chylomicrons) could well be more relevant to predicting risk than fasting triglycerides (VLDL).97,98

As one group of cardiologists observed: ‘Despite the considerable progress made in cardiovascular disease management in recent decades, there is almost unanimous agreement among epidemiologists and clinicians that coronary risk assessment based exclusively on LDL-cholesterol is not optimal …’.99

Despite these considerations, many patients present to herbal clinicians with a clear objective of using phytotherapy to lower elevated cholesterol. In such circumstances, given that herbs are not as powerful as statins, attention to other risk factors is also in the patient’s interest. One key herb with a broader activity on cardiovascular risk factors already discussed in the preamble is garlic (especially the allicin-releasing products or the uncooked crushed cloves). Fortunately this broader activity seems to be ‘built-in’ for many herbs, owing to the molecular promiscuity of their key constituents: turmeric is a good example of this.

As noted earlier, garlic appears to be able to lower plasma fibrinogen. Starting in the 1970s, elevated fibrinogen levels were shown to be a major independent cardiovascular risk factor. Higher fibrinogen levels enhance the CHD risk of patients with hypertension and diabetes and for cigarette smokers. Fibrinogen strongly affects blood rheology and coagulation, platelet aggregation. It is an acute-phase inflammation marker and has direct effects on the vessel wall. The association of fibrinogen with traditional cardiovascular risk factors and its independent contribution suggests it may play a mechanistic role by which the risk factors exert their effect, for example smoking, even LDL-cholesterol. Elevated LDL-cholesterol poses an ominous risk when accompanied by a high fibrinogen level. Reduction of high levels of fibrinogen with drugs reduces cardiovascular morbidity and mortality.100

Another interesting risk factor is lipoprotein(a) (Lp(a)). Apolipoprotein(a), a large glycoprotein made by the liver, is linked to an LDL particle to produce Lp(a). Lp(a) has been studied as a cardiovascular risk factor since the 1970s, but interest had declined in the mid-1990s owing to some underpowered epidemiological studies that found no link to cardiovascular disease. Investigation of Lp(a) has also been hampered by inconsistent approaches to its measurement. Several studies, culminating with a large meta-analysis of 126 000 participants published in 2009, have clearly returned Lp(a) to the cardiovascular risk agenda.101 Linear and independent associations were shown for Lp(a) levels and incidence of CHD and stroke. Two recent genetic studies suggest that this association is causal, at least in people of European ancestry.102 Ginkgo has been shown to reduce Lp(a) in a small clinical study (see Ginkgo monograph).

Even supporting the immune system and oral health of a patient with or at risk of atheroma might improve their cardiovascular health prospects. A review of the published literature concluded that strong evidence supports an association between acute coronary syndromes and acute respiratory infections.103 Both peak in winter and acute infections could precede up to a third of events. Large and well-designed retrospective studies consistently find a 2- to 3-fold increase in risk within 1 to 2 weeks after a respiratory infection. It is especially marked in the first few days (nearly a 5-fold increase). Up to half of all deaths during influenza epidemics are attributable to cardiovascular causes. Several, but not all, epidemiological studies have shown that Chlamydia pneumoniae antibodies may be related to the development of cardiovascular disease. Additionally Chlamydia seems to be present in atheroma, but not healthy arteries.104 A meta-analysis of 29 epidemiological studies found the risk of developing cardiovascular disease was a significant 34% higher in people with periodontal disease (7 cohort studies), and the odds ratio was 2.35 from 22 case-control studies.105

It should be kept in mind that the process of a heart attack has no direct relationship to cholesterol. Essentially there are three key factors that can lead to a dangerous heart attack. These are the rupture of vulnerable or unstable plaque in a coronary artery wall, the resultant formation of a massive clot or thrombus (thrombosis) that starves the heart of oxygen, and thirdly the dangerous rhythm disturbance that can follow when the heart is shocked in this way. Logically, this process would argue that, through stabilising plaque, making the blood less likely to clot and rendering the heart less prone to dangerous rhythm disturbances, the risk of a dangerous heart attack can be reduced.

Gotu kola could have a role in managing unstable plaque. Other key herbs that might also be useful in this scenario are garlic for blood quality and possibly hawthorn to protect heart rhythm. Vulnerable plaque is one that is at high short-term risk of rupture and plaque rupture is by far the most frequent cause of arterial thrombosis. It is deemed responsible for about 75% of coronary blockages leading to heart attacks and about 90% of carotid artery blockages causing ischaemic stroke. Only plaque with a very thin fibrous cap is at risk of rupture and even just a small area is life-threatening. These plaques are essentially unstable because of a deficiency of connective tissue. Even in the presence of widespread arterial disease, rarely more than a few plaques appear to be at risk of rupture at any given moment.106 One group of researchers observed: ‘It is not clear why some plaques lead to clinical manifestations, whereas many others remain asymptomatic and heal with subsequent fibrosis…’.107 In a sense, arterial plaque is a type of wound on the blood vessel wall and vulnerable plaque can be seen as either not healing appropriately, or in the early stages of healing (fibrosis).

Gotu kola may help this unstable plaque to heal. In two 12-month placebo-controlled clinical trials, gotu kola stabilised echolucent low density carotid108 and femoral artery plaque.109 (See the gotu kola monograph for more details.) Arterial plaque that is echolucent (low echogenicity by ultrasound) has a limited amount of connective tissue and the plaque is weaker and prone to ulceration and rupture. This is not quite the same as vulnerable coronary artery plaque, but shares many similarities. On the basis of these findings, it would be interesting to investigate the impact of the long-term intake of gotu kola on health outcomes in patients with coronary artery disease.

Treatment

Diet and lifestyle

Dietary treatment should be the first-line therapy for hyperlipidaemia, especially in those population groups where the benefit of more aggressive therapy has not been established. All common and most of the rarer types of hyperlipidaemia respond to diet therapy. Saturated fat intake should be reduced. Fibre, especially sticky soluble fibre from fruit, vegetables, legumes, oats and rice, should be increased. Fish consumption, especially of oily fish, should also be increased. There is benefit in the use of monounsaturated vegetable oils such as olive oil, and cholesterol intake should be reduced. Alcohol intake should be moderate and binge drinking avoided.110

One interesting protocol that synthesises several aspects of the above recommendations into a systematic approach is known as the ‘dietary portfolio’. A Canadian research team headed by David Jenkins has been clinically investigating this strategy for several years, with remarkable results. Their dietary portfolio has been the subject of more than 10 major publications and it is based on the concept of introducing foods that actively reduce cholesterol.111 In other words, it is a dietary approach based on ‘do’ rather than ‘don’t’. The dietary portfolio has four simple aspects:

• Plant sterols (as a supplement or in a functional food) about 2 g/day

• Viscous fibre (oat bran, psyllium, eggplant and so on) about 20 g/day

• Almonds about 30 g/day

• Soya protein about 40 g/day.

The most impressive study using the dietary portfolio was published in JAMA in 2003.111 Here participants were randomised into one of three interventions for 1 month:

• A control diet based on whole wheat cereals and low fat milk which was low in saturated fat

• The above diet plus lovastatin 20 mg/day

• The dietary portfolio.

For the control diet, an average decrease of LDL-cholesterol of 8% was observed. In contrast, those participants receiving the statin or on the dietary portfolio had mean decreases in LDL-cholesterol of 30.9% and 28.6% respectively. In other words, the dietary portfolio achieved a similar cholesterol reduction to a statin drug. Triglycerides were also reduced by 8%.

One key aspect of the dietary portfolio approach is that it incorporates a vegetarian diet, with a large part of the protein coming from soya. This is not acceptable to some patients; hence a partial approach (without the soya) could be adopted, combined with an appropriate selection of the herbal options discussed below.

Herbs

Key herbs to consider are Curcuma (turmeric), Allium sativum (garlic), Cynara (globe artichoke) and berberine-containing herbs (in extracts capable of delivering relatively high doses of berberine). Adequate doses of all these herbs need to be prescribed to achieve meaningful clinical results (see previous, and the relevant monographs). There are also some promising in vivo results for hawthorn berries (not the leaves, see the hawthorn monograph).

These herbs can be supported by saponin-containing herbs that are believed to sequester cholesterol in the digestive tract. Gymnema is rich in saponins and has been found to reduce cholesterol in vivo112 and in a clinical trial in type 2 diabetes.113Medicago sativa (alfalfa) seed has also been shown to lower cholesterol in a clinical trial.114 This may be due to both its saponin and mucilage content.

Mucilages are a class of polysaccharide related to soluble fibre. Soluble fibre such as guar gum is thought to lower cholesterol by several possible mechanisms. In particular, bacterial flora in the large bowel metabolise soluble fibre to produce short-chain fatty acids (SCFA). Some of these SCFA are carried by the portal venous system to the liver where they might influence hepatic metabolism to decrease cholesterol biosynthesis. Patients can supplement their soluble fibre intake with mucilages such as Ulmus (slippery elm), Althaea (marshmallow root) and seeds or hulls from Plantago species (psyllium, ispaghula). See also the discussion of mucilages in Chapter 2 for more data on the impact of psyllium on lowering plasma cholesterol in clinical trials.

Green tea consumption has been shown to significantly reduce serum cholesterol and triglycerides and increase HDL.115

Example herbal treatment

Cynara scolymus 1:2 45 mL
Gymnema sylvestre 1:1 35 mL
Crataegus laevigata berry 1:2 25 mL
  total 105 mL

Dose: 8 mL with water two to three times a day.

Together with allicin-releasing garlic tablets (equivalent to about 6 to 12 g/day of fresh garlic) and providing at least 12 mg/day of alliin).

Case history

A 74-year-old woman in good overall health was receiving ongoing treatment for emotional and digestive problems. In late 2006 her total serum cholesterol was elevated at 7.0 with LDL-cholesterol at 4.1 (and a high HDL). A powder formulation delivering 4.4 g/day Cynara, 1.85 g/day phytosterols and 4.0 g/day psyllium husks and other aspects of the dietary portfolio were recommended. The patient was able to comply with most of these, but did not like soya, so found taking it difficult. Hence that aspect of the treatment was left out. Around 10 weeks later her total cholesterol tested at 6.0, with an LDL reading of 3.2. Hence, a 22% reduction was achieved, even using the modified dietary portfolio without the soya, but with added Cynara.

Palpitations

Palpitations (undue awareness of the beating of the heart) can be a significant source of anxiety to the sufferer. The awareness is most commonly brought about by a benign change in the rhythm or rate of the heart (rather than the heart being actually damaged), amplified in the resonant chamber of a tense thoracic cavity. However, sinus tachycardia or less benign arrhythmias such as ventricular or atrial tachycardia, heart block or atrial fibrillation may be responsible. These factors should be excluded in diagnosis.

Treatment

Diet and lifestyle

A key element in palpitations is likely to be diaphragmatic spasm, unconscious tension in this large muscle and others in the wall of the chest. Palpitations (along with hyperventilation, some nervous dyspepsia and swallowing difficulties) are therefore an important indication for a coordinated programme of breathing exercises, best initiated under instruction. Patients should avoid excessive nicotine and caffeine intake. Intake of chocolate, cheese and synthetic food preservatives should be reduced. Vasodilator drugs and asthma or nasal treatments containing sympathomimetic (e.g. ephedrine) drugs should be reviewed. Excessive intake of the stimulant herbs Ephedra, Panax and Paulinia (guarana) and Cola should be avoided. Methods to reduce emotional stress should be advised.

Herbs

The combination of benign arrhythmias or ectopic beats with thoracic tension may be treated with Leonurus cardiaca (motherwort), Lycopus (bugleweed), Corydalis, Ginkgo, Salvia miltiorrhiza (dan shen) and particularly Crataegus (see available monographs).

Lycopus (bugleweed) must be considered if the patient’s thyroid is overactive. Emotional and mental tensions can be reduced with the above combined with herbs such as Valeriana, Scutellaria (skullcap), Passiflora, Piper methysticum (kava) and Hypericum (St John’s wort).

The dyspeptic and reflux conditions often associated with this syndrome should be treated with the appropriate upper digestive relaxants (see the Digestive system section).

Example liquid formula

Corydalis ambigua 1:2 20 mL
Crataegus laevigata leaf 1:2 30 mL
Leonurus cardiaca 1:2 15 mL
Ginkgo biloba (standardised extract) 2:1 20 mL
Scutellaria lateriflora 1:2 20 mL
    105 mL

Dose: 8 mL with water twice a day.

Chronic venous disorders

Varicose veins are a common disorder, with prevalence in the adult population of between 14% for large varices and 59% for small telangiectasias. The term chronic venous insufficiency (CVI) defines functional abnormalities of the venous system producing advanced symptoms including oedema, skin changes and leg ulcers. Both entities, varicose veins and CVI, may be summarised under the term chronic venous disorders, which includes the full spectrum of morphological and functional abnormalities of the venous system. Concerning the aetiology of venous disorders, controversial theories exist leading to different therapeutic concepts. There is probably a vicious circle between structural changes in valves and the venous wall and haemodynamic forces leading to reflux and venous hypertension. Chronic venous insufficiency requires chronic management.116

Varicose veins and CVI have long been regarded as disorders of valvular incompetence. However, recent evidence suggests that changes in the vein wall could well precede incompetence. For example, varicosities are often observed below competent valves and can occur before valvular incompetence. Defects in extracellular matrix and collagen composition in the vein wall are thought to be part of this process.117

Areas of intimal hyperplasia and smooth muscle cell proliferation are often noted in varicose veins, although regions of atrophy are also present. The total elastin content in varicose veins is reduced compared with non-varicose veins; changes in overall collagen content are uncertain. Matrix metalloproteinases (MMPs), including MMP-1, MMP-2, MMP-3, MMP-7 and MMP-9, and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-3 are upregulated in varicose veins. Activation of the endothelium stimulates the recruitment of leucocytes and release of growth factors, leading to smooth muscle cell proliferation and migration. Dysregulated apoptosis has also been demonstrated in varicose veins.117

Although there are few prospects for cosmetically changing established varicosities, herbal treatments stress the need to maintain good venous and connective tissue tone, so as to reduce further trouble and improve venous return from the lower body.

Treatment

Diet and lifestyle

Fruit and vegetable intake should be high to maintain optimum levels of flavonols and other supportive elements. Berries are particularly rich in vasoprotective phytochemicals. Regular walking, and resting or sleeping with the legs elevated, is often to be recommended. Elastic stockings should be useful, especially if applied first thing in the morning. Cold water applied to the legs from the knee to the foot can help to stimulate circulation and tone the area.

Herbs

Aesculus hippocastanum (horsechestnut) and Ruscus (butcher’s broom), taken internally and also applied topically in a cream, are key aspects of treatment (see monographs). These herbs are proven to increase venous tone. Aesculus should not be applied to broken skin.

Connective tissue stabilising herbs (pine bark and grape seed) and vasoprotective microvascular herbs (bilberry, Ginkgo, grape seed, pine bark and gotu kola) improve connective tissue function. Gotu kola has proven clinical benefits in venous insufficiency and a noted activity for connective tissue regeneration (see monograph).

Improve circulatory function with circulatory herbs, especially Ginkgo, Achillea (yarrow) and rosemary, and antiplatelet herbs such as turmeric.

Melilotus (sweet clover) has anti-oedema activity and improves venous return.

Bilberry’s benefits in venous insufficiency are supported by clinical trials and it has the advantage of being safe in early pregnancy (see bilberry monograph).

Herbs beneficial by topical application include Symphytum (comfrey), Arnica, Calendula and Hamamelis (witchhazel).

Example liquid formula

Aesculus hippocastanum 1:2 30 mL
Ruscus aculeatus 1:2 30 mL
Ginkgo biloba (standardised extract) 2:1 20 mL
Centella asiatica (standardised extract) 1:1 30 mL
  total 110 mL

Dose: 8 mL with water twice a day.

Stasis dermatitis and stasis ulceration

Stasis dermatitis (varicose eczema) develops in the legs as a result of chronic oedema and venous incompetence. It usually begins as a scaling associated with itching over the medial aspect of the ankle and can progress to become stained as a result of extravasation of blood.

Stasis ulceration (varicose ulcer) is a further complication of stasis dermatitis. The ulcers are shallow and can be quite large. They often result from damage such as knocking the leg and can take months or longer to heal. Bacterial infection is present.

Treatment

Treatment is essentially as for varicose veins, but the following additions or modifications are important to prevent further damage and heal any ulcer. Oral doses of Aesculus have demonstrated clinical benefit in varicose ulcers (see Aesculus monograph).

Aesculus or Ruscus should not be applied topically. The best topical treatments consist of Calendula and Echinacea root as a lotion and Calendula cream applied on the good skin around the edge of the ulcer.

Inclusion of Centella (gotu kola) for promotion of healing and Echinacea root for its immune effects in the oral treatment can be beneficial.

Case history

A 62-year-old woman had a very bad varicose ulcer, several centimetres in width. She had experienced problems with varicose veins for many years to the point where she could not stand still for any length of time (and had to do her ironing sitting down). Episodes of cellulitis in her legs also occurred from time to time. Her conventional medications were a thiazide diuretic and a cardioselective beta-blocker.

The following treatments were prescribed:

Ginkgo biloba (standardised extract) 2:1 20 mL
Centella asiatica 1:2 35 mL
Ruscus aculeatus 1:2 25 mL
Aesculus hippocastanum 1:2 20 mL
  total 100 mL

Dose: 5 mL with water three times daily.

Topical treatments consisting of:

• A 50/50 mixture of Calendula 1:2 and Echinacea angustifolia root 1:2 diluted one part with five parts of sterile water as a lotion for bathing the ulcer

• Calendula cream and comfrey cream which were to be applied to the good skin around the ulcer several times a day.

After about 4 weeks of treatment there was a noticeable improvement in the ulcer. With continued treatment over the next few months the ulcer healed and she could do her ironing standing up. The results of the herbal treatment had far surpassed her expectations.

Deep vein thrombosis

Under certain conditions, a thrombus, composed mainly of platelets and fibrin, can form in a deep vein. In 1856, Virchow described the classic triad of venostasis, hypercoagulability and vascular damage as predisposing factors. These factors underlie the many other risk factors that have been identified, such as surgery, oral contraceptives, air travel, cancer and pregnancy. A patient with a spontaneous deep vein thrombosis (DVT) has one chance in six of having cancer diagnosed within 2 years.

In at least 40% of cases, fragments of thrombus break loose to form a pulmonary embolus. This can be life threatening.

The management of acute DVT and any subsequent pulmonary embolism requires conventional acute medical care. However, phytotherapy does have a role in the prevention of DVT in those at risk, and in the management of the chronic compromised venous return that may subsequently develop (postphlebitic syndrome).

Prevention

Herbs that improve venous tone will decrease the likelihood of venostasis. Aesculus (horsechestnut) has been proven to reduce the risk of DVT in a clinical trial (see monograph). Other herbs listed under chronic venous insufficiency are also relevant.

Integrity of vessel walls can be maintained with OPC-containing herbs including hawthorn, grape seed and pine bark extracts.

Circulation and the quality of the blood can be improved with Ginkgo, dan shen, ginger, garlic and turmeric.

Postphlebitis syndrome

Treatment is similar to above (since recurrences must be prevented) but emphasis is also given to assist venous return and reduce oedema.

Collateral circulation can be promoted with exercise and herbs that improve circulation and the integrity of fine vessels such as Ginkgo, bilberry and grape seed extract.

Case history

A male patient aged 39 developed multiple DVTs in one leg and serious pulmonary embolism following a long intercontinental flight. As a result he was left with substantially impaired venous return in one leg, with a tendency to oedema in that limb.

He was prescribed herbal treatments with the aim of improving his venous return by enhancing venous tone and developing collateral circulation. Treatment was superimposed on a regular exercise programme and was as follows:

• Vein tablets (2 tablets/day) each containing:

Horsechestnut 1.2 g (standardised to contain 40 mg escin)
Butcher’s broom 800 mg (standardised to 20 mg ruscogenin)
Ginkgo biloba 1.5 g (standardised to contain 7.3 mg flavone glycosides)

As well as the following:

• Grape seed extract 50 mg tablets. Dose: 2 tablets/day

• Bilberry tablets 6000 mg (fresh weight) standardised to contain 15 mg anthocyanosides. Dose: 4 tablets/day

• Hawthorn leaf tablets (1000 mg). Dose: 2 tablets/day.

Over a period of 3 years there was a considerable improvement in his condition. He can walk and exercise without impairment and is largely free of symptoms.

Hypotension syndrome

Hypotension, or very low blood pressure, can be associated with a number of serious diseases, or can result from drug therapy. Current medical thinking does not associate any health issue with mild hypotension. In fact, mild hypotension (that is, blood pressure in the normal range but significantly lower than average) is considered to be beneficial.

However, herbalists recognise a syndrome associated with mild hypotension that can include depression, lack of energy and episodic dizziness or light-headedness. Some scientific studies now appear to support the existence of this syndrome.118 Hypotension has been associated with depression in the elderly119 and in the general population.120

The following herbs should be considered:

• Circulatory stimulants such as cayenne and prickly ash

• Ginkgo to improve nourishment of brain tissue and cerebral circulation (see monograph)

• Tonics especially Korean ginseng and adrenal trophorestoratives such as Rehmannia and licorice to help maintain blood pressure and energy

• St John’s wort is indicated for any associated depression

• Judicious use of herbs to increase blood pressure such as licorice at higher doses can be considered.

Example liquid formula

Ginkgo biloba (standardised extract) 2:1 20 mL
Zanthoxylum clava-herculis 1:2 15 mL
Hypericum perforatum 1:2 25 mL
Panax ginseng 1:2 15 mL
Glycyrrhiza glabra 1:1 25 mL
  total 100 mL

Dose: 8 mL with water twice daily.

Cerebral atherosclerosis and peripheral circulation disorders

Cerebral atherosclerosis can lead to vascular dementia, which is the second commonest cause of dementia (after Alzheimer’s disease). It can also lead to transient ischaemic attacks.

As with other disorders involving ischaemia, cerebrovascular risk factors should be identified and treated. For example, hypertension may increase the risk of dementia by inducing small vessel disease and white matter lesions (leukoaraiosis).121,122

Treatment

• The key herb is Ginkgo, used as the standardised extract in tablet or liquid form. Studies have shown that this extract can compensate for deficits associated with cerebral ischaemia. It may in fact prove to be a specific treatment for white matter disease (see Ginkgo monograph).

• Prickly ash can improve arterial circulation (traditional indication), but should not be used if hypertension is present. Rosemary and Salvia miltiorrhiza (dan shen) should also be considered to improve circulation.

• Garlic, especially in allicin-releasing preparations, improves flow in fine blood vessels and treats cardiovascular risk factors. Other antiplatelet herbs that may be beneficial include turmeric, ginger and Coleus.

• Herbs to boost cognitive function such as Bacopa, sage and Ginkgo should be used to compensate for any reduced cognitive function.

• Antioxidant and vasoprotective herbs such as bilberry and grape seed can be of value to minimise further deterioration.

• The same approach can be applied in peripheral vascular disease, poor circulation and Raynaud’s phenomenon.

• In addition, for Raynaud’s phenomenon, herbs with peripheral vasodilating properties such as cramp bark, hawthorn and Coleus could be considered.

Case history: Raynaud’s Phenomenon

A 60-year-old female patient developed Raynaud’s phenomenon in conjunction with scleroderma. On examination she had ischaemic signs on several fingertips in both hands. Her herbal treatment for this problem consisted of the following:

Zingiber officinale 1:2 10 mL
Ginkgo biloba (standardised extract) 2:1 20 mL
Crataegus folia 1:2 20 mL
Zanthoxylum clava-herculis 1:2 15 mL
Echinacea angustifolia root 1:2 35 mL
  total 100 mL

Dose: 5 mL with water three times a day.

This treatment was able to control her Raynaud’s symptoms and prevent the development of gangrene. Echinacea was included in the formula to help prevent infection in the ischaemic fingertips. The treatment did arrest the progression of ischaemic changes and over time improved the health of the fingertips.

Buerger’s disease

Buerger’s disease is an unusual chronic blood vessel disease.123,124 In 1908 Leo Buerger from New York first described a pattern of what he termed ‘presenile spontaneous gangrene’ due to a distinctive disease pattern he called thromboangiitis obliterans (literally the obliteration of blood vessels by inflammatory and clotting processes).125

Buerger’s disease is indeed an inflammatory, occlusive (blocking) disorder, affecting the small and medium-size arteries and veins.123 Typical patients are mostly young, male tobacco smokers and the clinical features include ischaemia in the limbs, leg ulcers and even gangrene of the fingers or toes.123 It is an unusual disorder because the large arteries supplying the heart, brain and abdominal organs are typically spared.125 The most serious outcome is amputation.

The average age at onset is 34 years and the male to female ratio is 7.5:1.125 The reported incidence in the US is around 10 cases per 100 000 population, making the total number of cases around 30 000. It has declined in incidence over the past 30 years, possibly because of less smoking. However, the application of a more strict diagnosis is another explanation for this decline.125 There is a much higher incidence in Eastern Europe, the Mediterranean, India, the Middle East and Japan and Korea.125 In Japan, Korea and India it can account for up to around half of all cases of peripheral vascular disease.125

The cause of Buerger’s disease is still unknown, although it has been suggested that it is an autoimmune response triggered when nicotine is present.126 Certainly, recent observations point to an endothelial dysfunction in arteries not yet involved (particularly impaired vasodilation), and there are elevated levels of antiendothelial cell antibodies.127 The histological appearance of the inflamed blood vessels does suggest immune involvement, with inflammation of the whole vessel wall and (typically) lymphocytic infiltration.128 Antiphospholipid antibodies as well as elevated levels of homocysteine have also been implicated,129 as has excessive exposure to arsenic via tobacco intake.130

On the last point, there can be no doubt that tobacco use in some form is crucial to the onset and progression of Buerger’s disease.125 The way the tobacco is ingested appears not to be critical, since the disease has developed in tobacco chewers and snuff users.125 Ceasing tobacco use favourably impacts the progression and recurrence of active disease and is the best means to avoid limb amputation.125

In terms of basic management, all forms of tobacco use and even nicotine patches should be avoided.131 Intravenous iloprost (a prostaglandin analogue) has shown clinical benefit.131 Arterial bypass and lumbar sympathectomy are surgical techniques used to avoid amputation, but appear to be of limited application and benefit.131

Treatment

There are few clinical data on the use of herbs in the management of Buerger’s disease, apart from some studies of traditional Chinese medicines.132,133 Dong quai (Angelica sinensis) has been successfully used to treat Buerger’s disease and constrictive aortitis, and is often combined with dan shen (Salvia miltorrhiza) in the treatment of peripheral vascular disorders.134

Case results for 200 cases of Buerger’s disease using a combination of traditional Chinese and conventional medicine were reported.135 The authors observed three key principles that they believed should be followed in the management of the disease. These were: (1) improve blood circulation and remove blood stasis; (2) control infection in any ischaemic lesions such as leg ulcers; (3) protect the blood flow and promote healing. These principles can also be applied using phytotherapy in the management of Buerger’s disease.

Given the above, and the factors and issues identified in the aetiology of Buerger’s disease, the following are suggested to be key herbs for managing this disorder:

• Ginkgo (Ginkgo biloba), dong quai, ginger (Zingiber officinale) and dan shen to improve peripheral circulation and tissue oxygen supply

• Echinacea root (Echinacea angustifolia and/or purpurea) to support immunity, control infection, promote healing and balance the autoimmune aspects136

• Hawthorn leaves (Crataegus species) to act as a peripheral vasodilator, support connective tissue and provide antioxidant activity

• Garlic (Allium sativum) as the allicin-releasing powdered bulb because of its clinically proven benefits in boosting the microcirculatory blood supply, enhancing fibrinolytic activity, lowering plasma fibrinogen and decreasing platelet aggregation.137 Garlic is also useful for managing heavy metal toxic exposure

• Gotu kola (Centella asiatica) to promote tissue healing and support the venous circulation (see monograph).

Case history

A male patient aged 55 presented with a diagnosis of Buerger’s disease. He also had cardiomyopathy (undetected at the time of initial presentation), possibly of viral origin, with considerable enlargement of the heart. The Buerger’s disease was diagnosed 20 years prior and, despite his having given up smoking for about 15 years (he had smoked for 18 years), was following a progressive course.

Circulation to his legs was severely compromised as assessed by Doppler flow analysis and he was told by his medical specialist to ‘get used to the idea of being in a wheelchair’. His walking was impaired, he had pain and his wife stated that his legs ‘felt dead’ when they brushed against her when they were lying in bed together.

Medical treatment consisted of two lumbar sympathectomies, one half an aspirin a day, enalapril maleate for his raised blood pressure and pentoxifylline. When his cardiomyopathy was discovered (about 1 year into herbal treatment) he was taken off pentoxifylline and placed on nifedipine.

The following herbal formula was prescribed:

Crataegus folia 1:2 30 mL
Salvia miltiorrhiza 1:2 30 mL
Ginkgo biloba (standardised extract) 2:1 20 mL
Echinacea angustifolia root 1:2 30 mL
Zingiber officinale 1:2 10 mL
Angelica sinensis 1:2 30 mL
  total 150 mL

Dose: 10 mL with water twice a day.

In addition he was prescribed two allicin-releasing garlic tablets (containing 6 mg each of alliin) per day.

Suggested dietary changes were to eat less meat and considerably more fruit and vegetables, especially berries.

Over 3 years of treatment there was a gradual and significant improvement. By his last visit before ceasing herbal therapy he was completely free of symptoms. Towards the end of herbal treatment the patient went on vacation and hiked 20 miles in one day with a pack. He has now taken up hiking over mountains as his hobby and can cover considerable distances for sustained periods, more than the average person.

Circulation had significantly improved in his feet and when he last went for Doppler flow measurements the hospital doctor told him the condition of his legs was so good that he did not require this test. His cardiologist was astounded that his heart had also improved. Ventricular function was now normal and his enlarged heart had reduced to near normal. This was an unexpected but welcome side effect of the herbal treatment.

References

1. Porkert M. The Theoretical Foundations of Chinese Medicine. Massachusetts: MIT Press, 1978. pp. 197–212

2. Oi Y, Okamoto M, Nitta M, et al. Alliin and volatile sulfur-containing compounds in garlic enhance the thermogenesis by increasing norepinephrine secretion in rats. J Nutr Biochem. 1998;9(2):60–66.

3. Sendl A. Allium sativum and Allium ursinum: Part 1. Chemistry, analysis, history, botany. Phytomedicine. 1995;4:323–339.

4. Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol. Ann Intern Med. 1993;119:599–605.

5. Silagy C, Neil A. Garlic as a lipid lowering agent – a meta-analysis. J R Coll Physicians Lond. 1994;28(1):39–45.

6. Simons LA, Balasubramaniam S, Von Konigsmark M, et al. On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis. 1995;113:219–225.

7. Isaacsohn JL, Moser M, Stein EA, et al. Garlic powder and plasma lipids and lipoproteins. Arch Intern Med. 1998;158:1189–1194.

8. Berthold HK, Sudhop T, Von Bergmann K. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial. JAMA. 1998;279(23):1900–1902.

9. Reinhart KM, Talati R, White CM, Coleman CI. The impact of garlic on lipid parameters: a systematic review and meta-analysis. Nutr Res Rev. 2009;22(1):39–48.

10. Lawson LD, Wang ZJ. Low allicin release from garlic supplements: a major problem due to the sensitivities of alliinase activity. J Agric Food Chem. 2001;49(5):2592–2599.

11. Orekhov AN, Pivovarova EM, Tertov VV. Garlic powder tablets reduce atherogenicity of low density lipoprotein. A placebo-controlled double blind study. Nutr Metab Cardiovasc Dis. 1996;6:21–31.

12. Breithaupt-Grogler K, Ling M, Boudoulas H, et al. Protective effect of chronic garlic intake on elastic properties of aorta in the elderly. Circulation. 1997;96(8):2649–2655.

13. Koscielny J, Klüssendorf D, Latza R, et al. The antiatherosclerotic effect of Allium sativum. Atherosclerosis. 1999;144(1):237–249.

14. Schiermeier Q. German garlic study under scrutiny. Nature. 1999;401(6754):629.

15. Koscielny J, Schmitt R, Radtke H, et al. Garlic study vindicated by official investigation. Nature. 2000;404(6778):542.

16. Vastag B. Garlic prevents plaque. JAMA. 2002;288(11):1342.

17. Silagy CA, Neil HAW. A meta-analysis of the effect of garlic on blood pressure. J Hyperten. 1994;12(4):463–468.

18. Tapsell LC, Hemphill I, Cobiac L, et al. Health benefits of herbs and spices: the past, the present, the future. Med J Aust. 2006;185(4 suppl):S4–S24.

19. Reinhart KM, Coleman CI, Teevan C, et al. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother. 2008;42(12):1766–1771.

20. Ried K, Frank OR, Stocks NP, et al. Effect of garlic on blood pressure: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2008;8:13.

21. Kiesewetter H, Jung F, Jung EM, et al. Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack. Eur J Clin Pharmacol. 1993;45:333–336.

22. Legnani C, Frascaro M, Guazzaloca G, et al. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects. Arzneimittel-Forschung. 1993;43(2):119–122.

23. Morris J, Burke V, Mori TA, et al. Effects of garlic extract on platelet aggregation: a randomized placebo-controlled double blind study. Clin Exp Pharmacol Physiol. 1995;22:414–417.

24. Ali M, Thomson M. Consumption of a garlic clove a day could be beneficial in preventing thrombosis. Prostaglandins Leukot Essent Fatty Acids. 1995;53:211–212.

25. Rendu F. L’ajoene, un antiagrégant efficace et subtil. Acta Bot Gallica. 1996;143(2/3):149–154.

26. Reuter HD. Allium sativum and allium ursinum: Part 2. Pharmacology and medicinal application. Phytomedicine. 1995;2(1):73–91.

27. Gadkari JV, Joshi VD. Effect of ingestion of raw garlic on serum cholesterol level, clotting time and fibrinolytic activity in normal subjects. J Postgrad Med. 1991;37(3):128–131.

28. Kiesewetter H, Jung F, Mrowietz C, et al. Effects of garlic on blood fluidity and fibrinolytic activity: a randomised, placebo-controlled, double blind study. Br J Clin Pract Symp Suppl. 1990;69:24–29.

29. Jung EM, Jung F, Mrowietz C, et al. Influence of garlic powder on cutaneous microcirculation. A randomized placebo-controlled double blind cross-over study in apparently healthy subjects. Arzneimittelforschung. 1991;41(6):626–630.

30. Anim-Nyame N, Sooranna SR, Johnson MR, et al. Garlic supplementation increases peripheral blood flow: a role for interleukin-6? J Nutr Biochem. 2004;15(1):30–36.

31. Lefer DJ. A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide. Proc Natl Acad Sci USA. 2007;104(46):17907–17908.

32. Benavides GA, Squadrito GL, Mills RW, et al. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA. 2007;104(46):17977–17982.

33. Rose KD, Croissant PD, Parliament CF, et al. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery. 1990;26(5):880–882.

34. Burnham BE. Garlic as a possible risk for postoperative bleeding. Plast Reconstr Surg. 1995;95(1):213.

35. Mohammed Abdul MI, Jiang X, Williams KM, et al. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol. 2008;154(8):1691–1700.

36. Lewis DA. Anti-Inflammatory Drugs from Plant and Marine Sources. Basel: Birkhäuser Verlag, 1989. pp. 137–164

37. Leung AY. Rutin. In: Leung AY, ed. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. New York: John Wiley, 1980.

38. Korkina LG, Durnev AD, Suslova TB, et al. Oxygen radical-mediated mutagenic effect of asbestos on human lymphocytes: suppression by oxygen radical scavengers. Mutat Res. 1992;265(2):245–253.

39. Negre-Salvayre A, Reaud V, Hariton C, Salvayre R. Protective effect of alpha-tocopherol, ascorbic acid and rutin against peroxidative stress induced by oxidized lipoproteins on lymphoid cell lines. Biochem Pharmacol. 1991;42(2):450–453.

40. Teofili L, Pierelli L, Iovino MS, et al. The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth. Leuk Res. 1992;16(5):497–503.

41. Blumberg S, Clough G, Michel C, Effects of Hydroxyethylrutosides on the Permeability of Frog Mesenteric Capillaries, Presentation to the AGM of the British Microcirculation Society, London, Department of Physiology, Charing Cross and Westminster Medical School, 1987.

42. Burnand K. Effect of hydroxylethyl rutosides on transcutaneous PO2 measurements. Proceedings of the Surgical Research Society, Leeds, 1987.

43. Wismer R. The actions of tri-hydroxyethylrutoside on the permeability of the capillaries in man. Praxis. 1963;52:1412.

44. Halborg-Sorenson A, Hansen H. Chronic venous insufficiency treated with hydroxyethylrutosides. Angiologica. 1970;7:192.

45. Belcaro G, Rulo A, Candiani C. Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements. Vasa. 1989;18(2):146–151.

46. McEwan AJ, McArdle CS. Effort of hydroxyethylrutosides on blood oxygen levels and venous insuffiency symptoms in varicose veins. BMJ. 1971;2:138–141.

47. Clifford MN. Diet-derived phenols in plasma and tissues and their implications for health. Planta Med. 2004;70(12):1103–1114.

48. Hollman PC, Katan MB. Bioavailability and health effects of dietary flavonols in man. Arch Toxicol Suppl. 1998;20:237–248.

49. Haeger K. The debatable value of flavonoids in venous insufficiency. Zbl Phlebol. 1967;6:23.

50. Chen ZY, Zhang ZS, Kwan KY, et al. Endothelium-dependent relaxation induced by hawthorn extract in rat mesenteric artery. Life Sci. 1998;63(22):1983–1991.

51. Nakamura Y, Matsumoto H, Todoki K. Endothelium-dependent vasorelaxation induced by black currant concentrate in rat thoracic aorta. Jpn J Pharmacol. 2002;89:29–35.

52. Chen CC, Chow MP, Huang WC, et al. Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships. Mol Pharmacol. 2004;66:683–693.

53. Stangl V, Lorenz M, Ludwig A, et al. The flavonoid phloretin suppresses stimulated expression of endothelial adhesion molecules and reduces activation of human platelets. J Nutr. 2005;135(2):172–178.

54. Kamata K, Kobayashi T, Matsumoto T, et al. Effects of chronic administration of fruit extract (Citrus unshiu Marc) on endothelial dysfunction in streptozotocin-induced diabetic rats. Biol Pharm Bull. 2005;28(2):267–270.

55. Ulicna O, Vancova O, Bozek P, et al. Rooibos tea (Aspalathus linearis) partially prevents oxidative stress in streptozotocin-induced diabetic rats. Physiol Res. 2006;55(2):157–164.

56. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr. 2005;81(suppl):243–255.

57. Chong MF, Macdonald R, Lovegrove JA. Fruit polyphenols and CVD risk: a review of human intervention studies. Br J Nutr. 2010;104(suppl 3):S28–S39.

58. Incandela L, Cesarone MR, DeSanctis MT, et al. Treatment of diabetic microangiopathy and edema with HR (Paroven, Venoruton; O-(beta-hydroxyethyl)-rutosides): a prospective, placebo-controlled, randomized study. J Cardiovasc Pharmacol Ther. 2002;7(suppl 1):S11–S15.

59. Oyama J, Maeda T, Sasaki M, et al. Green tea catechins improve human forearm vascular function and have potent anti-inflammatory and anti-apoptotic effects in smokers. Intern Med. 2010;49(23):2553–2559.

60. Schonlau F, Rohdewald P. Pycnogenol for diabetic retinopathy. A review. Int Ophthalmol. 2001;24(3):161–171.

61. Hertog MG, Feskens EJ, Hollman PC, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993;342(8878):1007–1011.

62. Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440–1446.

63. Hung HC, Merchant A, Willett W, et al. The association between fruit and vegetable consumption and peripheral arterial disease. Epidemiology. 2003;14(6):659–665.

64. Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. Int J Cardiol. 1995;49(3):191–199.

65. Bone K. Clinical Applications of Ayurvedic and Chinese Herbs. Warwick, Australia: Phytotherapy Press, 1996. pp. 103–107

66. Cheng TO. Cardiovascular effects of Danshen. Int J Cardiol. 2007;121(1):9–22.

67. Erdine S, Ari O, Zanchetti A, et al. ESH-ESC guidelines for the management of hypertension. Herz. 2006;31(4):: 331–: 338.

68. Yeater RA, Ullrich IH. Hypertension and exercise; where do we stand? Postgrad Med. 1992;91(5):429–434.

69. Beilin L. Epidemiology of hypertension. Med Int. 1993;24:351–355.

70. Kochar MS. Hypertension in obese patients. Postgrad Med. 1993;93(4):193–200.

71. Stolarz–Skrzypek K, Kuznetsova T, Thijs L, et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011;305(17):1777–1785.

72. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. (3):2004. CD004937

73. Berkow SE, Barnard ND. Blood pressure regulation and vegetarian diets. Nutr Rev. 2005;63(1):1–8.

74. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336(16):1117–1124.

75. Van Horn L, McCoin M, Kris-Etherton PM, et al. The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc. 2008;108(2):287–331.

76. Geleijnse JM, Witteman JCM, Bak AAA, et al. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. BMJ. 1994;309:436–440.

77. Blake GH, Beebe DK. Management of hypertension; useful nonpharmacologic measures. Postgrad Med. 1991;90(1):151–158.

78. Bonaa KH, Bjerve KS, Straume B, et al. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. N Engl J Med. 1990;322(12):795–801.

79. Ramsay LE, Yeo WW, Chadwick IG, et al. Non-pharmacological therapy of hypertension. Br Med Bull. 1994;50(2):494–508.

80. Bradley JG. Nonprescription drugs and hypertension; which ones affect blood pressure? Postgrad Med. 1991;89(6):195–202.

81. Susalit E, Agus N, Effendi I, et al. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with Captopril. Phytomedicine. 2011;18(4):251–258.

82. Noronha B, Duncan E, Byrne JA. Optimal medical management of angina. Curr Cardiol Rep. 2003;5(4):259–265.

83. Vandergoten P, Benit E, Dendale P. Prinzmetal’s variant angina: three case reports and a review of the literature. Acta Cardiol. 1999;54(2):71–76.

84. Hung J. Unstable angina: assessment and management. Mod Med. 1994;37(10):18–27.

85. Kandziora J. Crataegutt effect in coronary blood circulation disorders. EEG findings in exercise test. Munch Med Wochenschr. 1969;111:295–298.

86. Weng WL, Zhang WQ, Liu FZ, et al. Therapeutic effect of Crataegus pinnatifida on 46 cases of angina pectoris – a double blind study. J Tradit Chin Med. 1984;4(4):293–294.

87. Mahmood ZA, Sualeh M, Mahmood SB, Karim MA. Herbal treatment for cardiovascular disease the evidence based therapy. Pak J Pharm Sci. 2010;23(1):119–124.

88. Duan X, Zhou L, Wu T, et al. Chinese herbal medicine suxiao jiuxin wan for angina pectoris. Cochrane Database Syst Rev. (1):2008. CD004473

89. Ahn CM, Hong SJ, Choi SC, et al. Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction. Phytother Res. 2011;25(2):239–249.

90. Kullo IJ, Ballantyne CM. Conditional risk factors for atherosclerosis. Mayo Clin Proc. 2005;80(2):219–230.

91. Mahmoudi M, Curzen N, Gallagher PJ. Atherogenesis: the role of inflammation and infection. Histopathology. 2007;50(5):535–546.

92. Verschuren WMM, Jacobs DR, Bloemberg BPM, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures; twenty-five-year follow-up of the seven countries study. JAMA. 1995;274(2):131–136.

93. Walsh JM, Grady D. Treatment of hyperlipidemia in women. JAMA. 1995;274(14):1152–1158.

94. Weverling-Rijnsburger AWE, Blauw GJ, Lagaay AM, et al. Total cholesterol and risk of mortality in the oldest old. Lancet. 1997;350:1119–1123.

95. Oliver M, Poole-Wilson P, Shepherd J, et al. Lower patients’ cholesterol now. BMJ. 1995;310:1280–1281.

96. van Wijk DF, Stroes ESG, Kastelein JJP. Lipid measures and cardiovascular disease prediction. Dis Markers. 2009;26:209–216.

97. Morrison A, Hokanson JE. The independent relationship between triglycerides and coronary heart disease. Vasc Health Risk Manag. 2009;5(1):89–95.

98. Patel JV, Tracey I, Hughes EA, et al. Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy. Vasc Health Risk Manag. 2009;5:801–810.

99. Millán J, Pintó X, Muñoz A, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757–765.

100. Kannel WB. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids. 2005;40(12):1215–1220.

101. Danesh J, Erqou S. Lipoprotein(a) and coronary disease – moving closer to causality. Nat Rev Cardiol. 2009;6(9):565–567.

102. Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361(26):2518–2528.

103. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis. 2010;10(2):83–92.

104. Vainas T, Sayed S, Bruggeman CA, et al. Exploring the role of Chlamydia pneumoniae in cardiovascular disease: a narrative review. Drugs Today (Batrc). 2009;45(suppl B):165–172.

105. Blaizot A, Vergnes JN, Nuwwareh S, et al. Periodontal diseases and cardiovascular events: meta-analysis of observational studies. Int Dent J. 2009;59(4):197–209.

106. Thim T, Hagensen MK, Bentzon JF, et al. From vulnerable plaque to atherothrombosis. J Intern Med. 2008;263(5):506–516.

107. Schoenhagen P, Tuzcu EM, Ellis SG. Plaque vulnerability, plaque rupture, and acute coronary syndromes: (multi)-focal manifestation of a systemic disease process. Circulation. 2002;106(7):760–762.

108. Cesarone MR, Belcaro G, Nicolaides AN, et al. Increase in echogenicity of echolucent carotid plaques after treatment with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled, randomised trial. Angiology. 2001;52(suppl 2):S19–S25.

109. Incandela L, Belcaro G, Nicolaides AN, et al. Modification of the echogenicity of femoral plaques after treatment with total triterpenic fraction of Centella asiatica: a prospective, randomised, placebo-controlled trial. Angiology. 2001;52(suppl 2):S69–S73.

110. Cullum A. The link between diet and CHD. Practitioner. 1994;238:: 855–: 857.

111. Jenkins DJ, Kendall CW, Marchie A, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA. 2003;290(4):502–510.

112. Shigematsu N, Asano R, Shimosaka M, Okazaki M. Effect of administration with the extract of Gymnema sylvestre R. Br leaves on lipid metabolism in rats. Biol Pharm Bull. 2001;24(6):713–717.

113. Baskaran K, Kizar Ahamath B, Radha Shanmugasundaram K, et al. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J Ethnopharmacol. 1990;30(3):295–300.

114. Mölgaard J, von Schenck H, Olsson AG. Alfalfa seeds lower low density lipoprotein cholesterol and apolipoprotein B concentrations in patients with type II hyperlipoproteinemia. Atherosclerosis. 1987;65(1–2):173–179.

115. Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ. 1995;310:693–696.

116. Partsch H. Varicose veins and chronic venous insufficiency. Vasa. 2009;38(4):293–301.

117. Lim CS, Davies AH. Pathogenesis of primary varicose veins. Br J Surg. 2009;96(11):1231–1242.

118. Pilgrim JA, Stansfeld S, Marmot M. Low blood pressure, low mood? BMJ. 1992;304(6819):75–78.

119. Kim BS, Bae JN, Cho MJ. Depressive symptoms in elderly adults with hypotension: different associations with positive and negative affect. J Affect Disord. 2010;127(1–3):359–364.

120. Licht CM, de Geus EJ, Seldenrijk A, et al. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension. 2009;53(4):631–638.

121. Kalaria RN. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev. 2010;68(suppl 2):S74–S87.

122. Brown WR, Thore CR. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol. 2011;37(1):56–74.

123. Lazarides MK, Georgiadis GS, Papas TT, et al. Diagnostic criteria and treatment of Buerger’s disease: a review. Int J Low Extrem Wounds. 2006;5(2):89–95.

124. Frost-Rude JA, Nunnelee JD, Spaner S. Buerger’s disease. J Vasc Nurs. 2000;18(4):128–130.

125. Mills JL, Sr. Buerger’s disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg. 2003;16(3):179–189.

126. Lazarides MK, Georgiadis GS, Papas TT, et al. Diagnostic criteria and treatment of Buerger’s disease: a review. Int J Low Extrem Wounds. 2006;5(2):89–95.

127. Olin JW, Shih A. Thromboangiitis obliterans (Buerger’s disease). Curr Opin Rheumatol. 2006;18(1):18–24.

128. Frost-Rude JA, Nunnelee JD, Spaner S. Buerger’s disease. J Vasc Nurs. 2000;18(4):128–130.

129. Adar R, Papa MZ, Schneiderman J. Thromboangiitis obliterans: an old disease in need of a new look. Int J Cardiol. 2000;75:S167–S170.

130. Noël B. Thromboangiitis obliterans a new look for an old disease. Int J Cardiol. 2001;78(2):199.

131. Olin JW. Thromboangiitis obliterans Buerger’s disease. N Engl J Med. 2000;343(12):864–869.

132. Men J, Men J. TCM treatment of thromboangiitis obliterans – a report of 64 cases. J Tradit Chin Med. 2005;25(1):34–36.

133. Yang BH, Zhang SG. Study of thromboangiitis obliterans treated with ‘vascular no. 3’ using Doppler ultrasound. Zhong Xi Yi Jie He Za Zhi. 1989;9(10):596–598.

134. Bone K. Clinical Applications of Ayurvedic and Chinese Herbs. Warwick: Phytotherapy Press, 1996. p. 5

135. Zhao XD, Jin X. Clinical analysis of 200 cases of necrotic thromboangiitis obliterans. Zhong Xi Yi Jie He Za Zhi. 1990;10(12):729–731.

136. Bone KM. Autoimmune disease: a phytotherapeutic perspective. Townsend Lett Doctors Patients. 1999;193/194: 94–98.

137. Bone KM. Cardiovascular activity of garlic powder products. Townsend Lett Doctors Patients. 2002;229/230:46–48.

Respiratory system

Scope

Apart from their use to provide non-specific support for recuperation and repair, specific phytotherapeutic strategies include the following.

Treatment of:

• inflammatory catarrhal conditions of the upper respiratory mucosa (e.g. common cold, rhinitis, sinusitis, otitis media)

• acute bronchial and tracheal infections

• allergic rhinitis

• nervous coughing patterns.

Management of:

• chronic obstructive pulmonary diseases (chronic bronchitis, bronchiectasis, emphysema, silicosis)

• asthma

• chronic tracheitis

• coughing due to persistent local irritation.

Because of its use of secondary plant products, particular caution is necessary in applying phytotherapy in cases of known allergic reactions to specific medicinal plant products.

Rationale and orientation

To the Chinese, the lungs were the internal organs most in contact with the exterior. So as well as ascribing to them the source of the body’s rhythm and the site of the catalysis of vital energies, they were seen to be the organs in charge of defences. In earlier times the role of the respiratory system was obvious in all cultures; the first cry was generally taken to be the first sign of life, the bronchial gasp on the deathbed the last, and a consistent fear throughout history was the hacking, bloody cough of consumption or tuberculosis, the disease that once cast its baleful influence over the popular imagination like cancer and AIDS now do, the constant reminder of how fatal debility followed weakening of the lungs. It was obvious that the lungs, even more than the stomach, were susceptible to contagion, the conceptual medieval precursor to viruses and bacteria. In this imagery, the key to resistance lay not in attacking alien invaders but in strengthening innate resources. Traditional strategies for treating respiratory disease were notably founded on supportive and tonifying remedies. Given that the modern virus remains as elusive as it ever was, an emphasis on supporting defences may seem appropriate again.

Modern interpretations of respiratory illness have shifted in recent years to identifying underlying inflammatory processes, involving leukotrienes and cytokines. Given that most pathologies have a strong inflammatory element, this is a promising avenue of further research for phytotherapy.1

This is, however, the one area where the divide between traditional and modern approaches is not very wide. Elsewhere, there are very few modern endorsements of early treatment strategies.2 Modern medical science, which at first embraced such agents in the earlier part of this century, now sees no role for their use. For example, modern editions of Martindale’s Extra Pharmacopoeia claim that: ‘There is little evidence to show that expectorants are effective’. Some modern drugs may have expectorant activity, such as bromhexine, but they are usually referred to as ‘mucolytic’. The impact of traditional remedies on the respiratory system is relatively poorly researched. Reliable external measures of change in mucosal function are elusive; many respiratory diseases are either self-limiting or are among some of the most persistent conditions in the clinic. Even in asthma, where peak flow rates provide a simple measure of benefit, the complexity of the condition and the usual presence of confounding and violent influences make easy characterisation of the condition, and the measurement of all but the most powerful across-the-board remedies, unreliable.

A sense that traditional approaches should be relegated to history is possibly reinforced in the medical psyche by the knowledge that one of the most dramatic advances of modern drugs was in controlling at last the old scourge of tuberculosis. However, this dismissal is not as conclusive as once thought. Tuberculosis is making a serious come-back on the world stage, attacking first the very impoverished and malnourished as it always did. As modern drugs struggle with this new manifestation, there may once again be value in looking at the lessons from the past, that treatment should be based on supportive remedies in a regime of convalescence. With the luxury of choice, with the option of taking modern drugs where these are necessary, but also being able to select more supportive strategies at other times, there is real value in reviewing the treatments forged out of desperate but not always unsuccessful battles with disease in earlier times. These lessons are fortunately quite well learnt.

The dominant feature of respiratory conditions is how readily changes in their behaviour are appreciated subjectively. The often immediate effects of eating and drinking different foods and drinks, of temperature and humidity changes and of the various treatments used through history have been the main guide in determining therapeutic strategy. From such experience has come the view of the respiratory mucosa and musculature as being particularly sensitive to reflex responses, notably from the upper digestive tract, from the pharynx to the stomach. There is a persistent tradition in many cultures that respiratory problems are extensions of digestive dysfunctions. Embryology supports such links, with the bronchial tree originating as a diverticulum of the pharyngeal zone of the alimentary duct and sharing common vagal innervation, and the association, for example, between asthma and histamine H2 receptors in the stomach3 add further support to such connections.

Phytotherapeutics

Part of the problem with expectorants probably arises from confusion over their definition. Another stems from the difficulties involved with measuring their efficacy.

Overview of expectorants

• An expectorant is a substance that enhances those physiological mechanisms by which respiratory tract secretions are cleared from the lungs. In the course of doing this they often render the consistency of respiratory tract secretions more fluid and/or more demulcent. They do not necessarily increase the quantity of coughed-up phlegm, nor are they necessarily antitussive (see below).

• Since reflex and warming expectorants act by different mechanisms, and on different parts of the lung tissue, an effective herbal prescription can combine these two types of expectorants, but depending on the patient’s condition as noted above.

• The effect and mechanism of action of reflex expectorants have been demonstrated by scientific experiments. However, since their effect seems to involve vagal stimulation of secretory glands, there may also be vagal stimulation of smooth muscle tissue in the lungs. Hence they should be used with caution in asthma, and combined with bronchiolar spasmolytics (but not anticholinergics that can dry respiratory secretions).

• Many lower respiratory tract disorders will benefit from the action of expectorants, but particularly those where mucus is tenacious and difficult to cough up. However, it depends on the cause of a cough whether an expectorant action is also antitussive.

The four definitions of expectorants given below highlight the difficulties. The dictionary meaning is only concerned with the actual oral production of phlegm or sputum. Since the majority of mucus produced from the lungs is swallowed, this definition is clearly unsatisfactory. Definitions from the pharmacologists Boyd and Lewis are more useful, but probably the best definition comes from Brunton, a 19th century pharmacologist. Brunton’s functional definition best explains the various ways in which medicinal plants can act as expectorants.

Definitions of expectorants

• Oxford Dictionary – ‘Promoting the ejection of phlegm by coughing or spitting.’

• Boyd (1954) – ‘An expectorant may be pharmacologically defined as a substance which increases the output of demulcent respiratory tract fluid.’

• Lewis (1960) – ‘Expectorants increase the secretions of the respiratory tract and so reduce the viscosity of the mucus which can then act as a demulcent. By virtue of the presence of increased quantities of fluid mucus, expectorants produce a “productive cough” which is less exhausting and less painful to the patient.’

• Brunton (1885) – ‘Remedies which facilitate the removal of secretions from the air passages. The secretion may be rendered easier of removal by an alteration in its character or by increased activity of the expulsive mechanism.’

Why expectorants?

Many respiratory conditions are characterised by abnormal mucus (catarrh) that can narrow airways. This abnormal mucus may be thick and tenacious and hence very difficult to clear from the airways.

If expectorants can render this catarrh more fluid and/or assist in its expulsion, then a clinical benefit should be achieved.

Expectorants can help to relieve debilitating cough. The presence of an irritation in the airways (such as tenacious abnormal mucus) invokes the cough reflex. (The cough reflex is most sensitive in the trachea and larger airways. The sensitivity progressively decreases in the finer airways and in the very fine airways there is no reflex at all. So in alveolitis, there is little stimulation of the cough reflex, whereas for tracheitis the stimulus is strong.) By clearing abnormal mucus or by changing its character and making it more demulcent, expectorants can allay cough and are therefore antitussive.

In spite of the incomplete scientific case and lack of a consensus orthodox view, traditional approaches to expectoration are strong and consistent across cultures and history. They include mechanisms that are rational and usually immediately apparent.

The following are categories of herbal remedies acting on the respiratory tract.

Stimulating (reflex) expectorants

These are remedies that provoke increased mucociliary activity by reflex stimulation of the upper digestive wall. The classic examples were originally used as emetics. It was noted that this drastic action was accompanied by a noticeable expectoration. In fact, traditional practitioners in Britain used emesis as a technique to clear the lungs in asthma and chronic bronchitis until quite recent times. Application of these remedies in sub-emetic doses was thus a consistent feature in all major herbal traditions. Herbs such as ipecacuanha, squills and Lobelia have been standards in Western medicine. There is some limited modern investigation of mechanisms involved. For example, ipecac-induced emesis is thought to be mediated through both peripheral and central 5-HT3 receptors.4 Other plants have been used as stimulating expectorants, although not used as emetics; members of the Primula, Bellis, Saponaria and Polygala genera are often included in this category in Western traditions. High saponin levels seem to be a common feature of this group and saponins are certainly nauseating in high doses.

Plant remedies traditionally used as stimulating (reflex) expectorants

• Cephaelis (ipecacuanha), Lobelia inflata (Lobelia), Urginea (squills), Primula veris (cowslip), Bellis (daisy), Saponaria (soapwort), Polygala senega (snakeroot).

Indications for stimulating expectorants

• Cough linked to bronchial congestion, especially where mucus is thick and tenacious or where there is unproductive cough

• Bronchitis, emphysema.

Other traditional indications for stimulating expectorants

• In some cases as emetics in higher doses.

Contraindications for stimulating expectorants

Although there is no firm evidence of unsuitability, as gastric irritants they can transiently upset some individuals (immediately relieved by withdrawing or changing the remedy). In addition, the use of stimulating expectorants should be kept under review in cases of:

• dry and irritable conditions of the lungs

• asthma

• young children

• dyspeptic conditions.

Application

Stimulating expectorants are best taken in hot infusions or as tinctures or fluid extracts, before food.

Long-term therapy with stimulating expectorants is appropriate in the management of chronic bronchial conditions as long as digestive functions are not affected.

Advanced phytotherapeutics

Stimulating expectorants may also be usefully applied in some cases (depending on other factors) of rheumatic and connective tissue diseases.

Warming expectorants (mucolytics)

Many of the spices were highly prized in the cold damp climates of northern Europe for their apparent ability to counteract associated chest problems. In particular, ginger had an almost mythical reputation; where this or imported cinnamon and cloves were not available, Europeans resorted to fennel, aniseed, garlic, mustard and horseradish for the same ends. Later cayenne or chilli peppers were used for this purpose, although generally taken to be too drying in most cases. The effect of the pungent spices probably includes increased blood flow to the respiratory mucosa, a reflex irritation of the upper digestive mucosa (as with the stimulating expectorants) and, especially in the sulphur-containing garlic and mustard family, a decrease in the thickness of mucus by altering the structure of its mucopolysaccharide constituents; the sensation usually is of a clearing of catarrh and the shifting of congestion up from the lungs.5 A simple infusion of fresh ginger and cinnamon remains one of the most effective home treatments for the common cold.

Essential oils from various herbs (either administered as essential oils or contained in herbal extracts or tinctures) are the most important agents that directly influence goblet cells to secrete more respiratory tract fluid and mucus. Boyd studied the effects of several essential oils in various experimental models (see Chapter 2). The most pronounced increase of respiratory tract fluid was seen after ingestion of oil of anise. Interestingly ingestion of oil of eucalyptus had a moderate effect that was not eliminated by cutting afferent gastric nerves. This finding supports the premise that essential oils do not generally act as reflex expectorants.

Plant remedies traditionally used as warming expectorants

• Pimpinella anisum (aniseed), Cinnamomum zeylanicum (cinnamon), Foeniculum (fennel), Zingiber (ginger), Allium sativum (garlic), Angelica archangelica (angelica).

Indications for warming expectorants

• Productive cough associated with cold

• Bronchitis, emphysema

• Profuse catarrhal conditions

• Dry cough, as per Boyd.

Other traditional indications for warming expectorants

• As aromatic digestives

• Congestive chronic infections and inflammatory conditions.

Contraindications for warming expectorants

The use of warming expectorants may be contraindicated or inappropriate in gastro-oesophageal reflux.

Traditional therapeutic insights into the use of warming expectorants

There is a close association in traditional medicine between catarrhal congestion and the digestive/assimilative functions. The warming remedies were seen to act seamlessly across both respiratory and digestive functions treating disturbances in either or both together. Symptoms most often found with catarrhal conditions might include abdominal distension, loss of appetite and loose stools.

Applications

Warming expectorants are best taken immediately before meals. They are particularly effective taken in hot aqueous infusions.

Long-term therapy with warming expectorants is usually acceptable.

Respiratory demulcents

These herbs contain mucilage and have a soothing and anti-inflammatory action on the lower respiratory tract. Although the mechanism is not clear, an opposite effect to that of the stimulating expectorants has been postulated; that is the effect is a reflex one from the demulcent effect on the pharynx and upper digestive tract, again involving common embryonic origins and vagal innervation.

The major respiratory demulcent herbs are Althaea officinalis (marshmallow root or leaves) and other members of the Malvaceae (mallows), Ulmus spp. (slippery elm), members of the Plantago genus, Cetraria islandica (Iceland moss) and Chondrus crispus (Irish moss). Tussilago (coltsfoot) and Symphytum (comfrey) were very widely popular before concerns about pyrrolizidine alkaloids constrained their sale.

Pronounced antitussive activity has been demonstrated experimentally with oral doses of 1000 mg/kg body weight of extract of Althaea officinalis (marshmallow), with comparable effects at 50 mg/kg of the isolated polysaccharides.6 These animal studies might suggest enormous doses necessary for clinical effect but if, as implied, the effect is a mechanical one, it is likely that only marginal increases in dose would be necessary to have similar impact in larger animals like humans (see also Chapter 2 under Mucilages).

Respiratory demulcents were popular for children’s cough and generally for dry, irritable and ticklish coughing. They were seen as intrinsically contraindicated in wet, damp chest problems, although they can sometimes be quite well suited to these if there is an irritable element.

Plant remedies traditionally used as respiratory demulcents

• Althaea (marshmallow), Plantago spp. (ribwort and plantain), Verbascum (mullein, especially leaf), Chondrus (Irish moss), Cetraria (Iceland moss), Glycyrrhiza (licorice).

Indications for respiratory demulcents

• Dry, non-productive, irritable cough

• Coughing in children

• Asthmatic wheezing and tightness.

Other traditional indications for respiratory demulcents

• As mucilaginous digestive remedies

• The effects of dryness on the respiratory system.

Contraindications for respiratory demulcents

The use of respiratory demulcents may be inappropriate in profuse catarrhal or congestive conditions of the mucosa (but see above).

Traditional therapeutic insights into the use of respiratory demulcents

As with other respiratory remedies, there is a close association between effects here and on the digestive tract. Respiratory demulcents are at their most appropriate if there are parallel indications in the gut: dry inflamed conditions such as gastritis and oesophagitis associated with hyperacidity, dry constipation and its various associated problems.

Application

Respiratory demulcents are best taken before meals. They are particularly effective taken in cold aqueous infusions. However, if gastro-oesophageal reflux is contributing to the pathology, as can be the case in asthma, they should be taken after meals.

Long-term therapy with respiratory demulcents is usually well tolerated.

Respiratory spasmolytics

Respiratory spasmolytics relax the bronchioles of the lungs. Traditionally they included the solanaceous plants (the nightshade family) with powerful atropine-related antiparasympathetic constituents: Datura, Atropa and Solanum were the prominent antiasthmatics of early history. As could now be explained pharmacologically, these remedies tended also to dry up the mucosa and had other less desirable effects, so less powerful remedies were also popular. Ephedra sinica (ma huang) from Asia was popular when it reached Europe and works through a sympathomimetic action. Other gentle remedies include culinary herbs such as hyssop and especially thyme, horehound, the North American gumplant, Grindelia camporum and elecampane (Inula helenium).

Plant remedies traditionally used as respiratory spasmolytics

• Ephedra (ma huang), Datura stramonium (jimson weed), Atropa belladonna (deadly nightshade), Solanum dulcamara (bittersweet), Hyssopus (hyssop), Thymus vulgaris (thyme), Lobelia inflata (lobelia), Marrubium vulgare (horehound), Grindelia camporum (gumplant), Euphorbia hirta (pill-bearing spurge), Coleus forskohlii, Glycyrrhiza (licorice), Inula (elecampane).

Indications for respiratory spasmolytics

• Tight, breathless, non-productive coughing

• Wheezing and other asthmatic symptoms.

Other traditional indications for respiratory spasmolytics

• Many of the gentler remedies were used as relaxants

• The solanaceous plants have potent neuroactive properties.

Contraindications for respiratory spasmolytics

The use of respiratory spasmolytics may be contraindicated or inappropriate in the following:

• In the case of solanaceous plants: glaucoma, urinary retention, paralytic ileus, intestinal atony and obstruction

• In the case of Ephedra: appetite disorders, glaucoma, prescription of monoamine oxidase (MAO) inhibitors.

Application

Respiratory spasmolytics may be taken at any time of the day as required for immediate effect.

Long-term therapy with respiratory spasmolytics is acceptable in the case of the gentler examples, but not for the solanaceous plants or Ephedra, and in all cases there should be attention to treatment of underlying causes rather than relying on symptomatic relief.

Anticatarrhals

There are a range of popular herbal treatments for a range of respiratory mucosal conditions whose action still remains mysterious. Indications for their use range from catarrhal congestion to some types of mucosal hypersensitivity such as hayfever and allergic rhinitis.

Plant remedies traditionally used as anticatarrhals

• Euphrasia spp. (eyebright), Plantago lanceolata (ribwort), Sambucus nigra flowers (elder), Mentha piperita (peppermint), Nepeta hederacea (ground ivy), Solidago virgaurea (goldenrod), Verbascum thapsus (mullein flowers) and Hydrastis canadensis (golden seal). Ephedra also has pronounced anticatarrhal activity.

Anticatarrhal herbs for the upper respiratory tract include eyebright, ribwort, Ephedra, elder, peppermint, ground ivy and golden seal. Golden seal is particularly indicated where there is copious yellow to green discharge of a chronic nature. Golden rod may also fit into this category. Anticatarrhal herbs for the lower respiratory tract include mullein, Ephedra and ribwort.

Sage has a general drying effect on bodily secretions including the mucous membranes and may be indicated where secretions are particularly copious and watery.

Indications for anticatarrhals

• Catarrhal conditions of the upper and lower respiratory tract

• Sinusitis, otitis media

• Allergic rhinitis, asthma and other hypersensitivity conditions.

Contraindications for anticatarrhals

Anticatarrhals are generally regarded as gentle and safe.

Application

Anticatarrhals are best taken before meals. Long-term therapy with anticatarrhals is usually well tolerated.

Herbs modulating inflammation and allergy

The inflammatory basis of many respiratory conditions has been clearer in recent years, with the role of dietary approaches, for example increasing the consumption of omega-3 fatty acids, being increasingly justified.7 The role of plant flavonoids and phenolics (such as the proprietary remedy Pycnogenol derived from the Pinus pinaster – maritime pine) as at least an adjunct for inflammatory respiratory conditions such as allergic rhinitis8 and childhood asthma9 has been supported in double blind, controlled clinical trials against placebo. Traditional remedies such as Ephedra and Scutellaria baicalensis (Baical skullcap) have been refocused on the management of mild asthmatic conditions.

A number of herbs in recent years have accumulated a reasonable evidence base of efficacy in dealing with upper respiratory disease and in asthmatic symptoms. In the first instance, research has been driven by products in the over-the-counter (OTC) industry, given that ‘cough-cold’ is the largest single OTC sector, especially in winter. Generally these remedies have in common preclinical research pointing to various anti-inflammatory activities, but there is little suggestion that they have antiviral or other wider asthmatic properties. The remedies most researched in this area include Petasites hybridus (butterbur) and the South African Pelargonium sidoides (umckaloabo).

Petasites is a traditional European remedy that has been used less in recent years since its pyrrolizidine alkaloid (PA) content was confirmed. Two pyrrolizidine alkaloid reduced proprietary extracts, one from the root and one from the leaf, have come on the market with claims to treat allergic rhinitis and migraine. Preclinical studies have shown that the sesquiterpenes isopetasin, oxopetasin and petasin are active constituents. They have demonstrated smooth muscle relaxant activity and in addition their esters inhibited the in vitro synthesis of leukotrienes, COX-2 and PGE2.10 Clinical trials of the efficacy of Petasites in allergic rhinitis have included a significant study showing comparability with a conventional antihistamine11 and one showing reduced reaction to the inflammatory agonist adenosine monophosphate (AMP).12 Other trials have been smaller or less rigorous,13 though add to the case for this new discovery.

Pelargonium is known in Germany for a range of respiratory conditions including acute bronchitis and has been marketed more widely as an OTC remedy for the common cold. In the former indication the clinical evidence, drawn from six randomised controlled trials, was judged as ‘encouraging’ in a recent meta-analysis.14 In relation to the common cold, a Cochrane review was tentatively positive in its conclusions, albeit from limited evidence (see also Chapter 2).15

There is less evidence for a proprietary preparation based on Sambucus nigra (elderberry), which as well as showing some promise clinically in the treatment of colds, has stimulated anti-inflammatory cytokines in human monocytes ex vivo.16

Plant remedies traditionally used as anti-inflammatory or antiallergy remedies

• Ephedra, Albizia lebbek and Scutellaria baicalensis (Baical skullcap), Tylophora indica et cordifolia (Indian ipecac),17Picrorhiza kurroa, Coleus forskohlii, Urtica (nettle leaf) Boswellia serrata (frankincense)18 and Hedera helix (ivy).19

Indications for anti-inflammatory or antiallergy remedies

• Mild and chronic asthmatic symptoms, including reactive wheeziness even without diagnosis of asthma

• Allergic rhinitis and other hypersensitivity conditions.

Contraindications for anti-inflammatory or antiallergy remedies

Any remedy that might modulate anti-inflammatory activity in the body needs to be applied with caution in autoimmune disease, although actual interactions with such conditions has not been widely reported.

Application

Most of the remedies in this category are appropriate for relatively long-term use and may need some weeks to demonstrate benefits.

Antitussives

Antitussives are remedies that allay coughing. Some may work through soothing irritability (respiratory demulcents); others are claimed to relieve coughs at source, by removing congestive mucus or other mobile provocations (expectorants).

However, the term ‘antitussive’ is often used specifically to refer to remedies that depress the cough reflex and, in particular in herbal terms, to those with appreciable levels of cyanogenic glycosides. The notable example in the Western tradition is Prunus serotina (wild cherry). Another tradition was to use opiates, and the gentle version of that strategy, Lactuca (wild lettuce), is still applied to the problem in some traditions. Hops (Humulus lupulus) were also used for the same reason. Such cough suppressants are not ideal treatments and could even be counterproductive if they reduce cleansing of the lungs. However, there are many cases where they provide helpful relief and they may be the only solution for coughing not due to movable irritants (for example, nervous cough on the one hand, tumours on the other).

Plant remedies traditionally used as antitussives

• Prunus serotina (wild cherry bark), Lactuca (wild lettuce), Glycyrrhiza (licorice), Bupuleurum.

Indications for antitussives

• Non-productive, severe or persistent cough refractory to expectorants

• Nervous cough

• Cough due to external irritation or obstruction (e.g. tumour).

Contraindications for antitussives

Antitussives should be used only as needed and limited as soon as practical.

Application

Antitussives are best taken before meals.

Long-term therapy with antitussives is not advisable, except for palliative care.

Topical agents

Throat applications

The surfaces at the back of the mouth and pharynx are the first point of contact for ingested or inhaled pathogens and irritants; the dense masses of lymphatic tissue in the region confirm their important role in defence. The use of gargles, lozenges and cough drops to mobilise local defences can be an effective way to encourage the body’s response to a wide range of respiratory infections. In the case of sore throats, demulcent remedies such as licorice and marshmallow,20 and astringents such as sage (Salvia species) and Hamamelis (witchhazel) could at least reduce irritation, and there are a range of remedies with more substantial reputations as topical anti-inflammatories. These can be used as levers to improve resistance and recovery in rhinitis, sinusitis and otitis as well as treating more local inflammations. Rather than attempting local antisepsis, resinous tinctures such as Calendula and myrrh, balm of Gilead, propolis and Tolu balsam appear to mobilise activity in the surrounding lymphatic tissues through the mildly provocative effect of their resins and essential oils. Other essential oil herbs can provide a mild antiseptic activity, for example thyme (Thymus vulgaris).

Plant remedies traditionally used as throat applications

• Calendula officinalis (marigold), Commiphora molmol (myrrh), Populus gileadensis (Balm of Gilead) – all in 90% alcohol extraction and most effectively combined with 1:1 or 1:2 extracts of Glycyrrhiza glabra (licorice); Salvia officinalis (sage), Thymus vulgaris (thyme); (for more soothing action) tannin- or mucilage-containing herbs such as Althaea officinalis (marshmallow), Rubus nigra (blackberry leaf), Hamamelis virginiana (witchhazel) and Ulmus fulva (slippery elm).

Indications for throat applications

• Sore and inflamed throats

• Persistent or recurrent upper respiratory infections, sinusitis, otitis media

• Gum disease and dental caries.

Contraindications for throat applications

Occasionally a very inflamed throat with enlarged lymphatic tissues (e.g. tonsillitis) may make the throat tissues too sensitive; this can usually be rectified with more licorice or other mucilaginous or tannic content.

Application

Throat applications are best taken between meals and at least 10 minutes before eating or drinking.

Inhalations

The obvious topical applications for the respiratory mucosa, traditional approaches to inhalations included smoking (Datura for asthma, for example, a high-risk treatment not recommended today), inhaling steam from herbal infusions to relieve congestion, and simple humidification. When the technology for extracting essential oils was developed these were frequent applications. Most apparent activity is found with the oils from mints (especially menthol), Eucalyptus, camphor, the Melaleuca family (tea tree – M. alternifolia, cajuput – M. leucadendron, niaouli – M. viridiflora), the Artemisia family (especially the aromatic A. abrotanum or southernwood21) and the pine family (turpentine – Pinus palustris, P. sylvestris, P. excelsa). These were widely used for symptomatic relief of respiratory congestion, although in the case of menthol there are doubts as to the real benefits (see peppermint monograph).22 It is possible that some volatile principles could exert anti-inflammatory effects23 (steam inhaled from chamomile flower infusions in some allergic rhinitis and pine oils in bronchitis, for example). Small doses of volatile oils may have a complex combination of activities, either reducing or stimulating ciliary activity24 or mucosal secretions.25 (See also Essential oils in Chapter 2.)

Multipurpose remedies

As can be seen from the above, some herbs may fall into several categories. This is because they contain either several active components or a group of active components acting in several different ways. For example, Verbascum (mullein) contains saponins that are expectorant, mucilage that is demulcent and iridoids that are anticatarrhal. Lobelia, although an emetic and stimulating expectorant, was used primarily as a relaxant remedy in 19th century North America; it thus has a broad spectrum of effects on the respiratory system. Probably the broadest acting remedy in common use, however, is Glycyrrhiza (licorice) which combines a saponin stimulant effect, a soothing effect and appreciable anti-inflammatory properties.

Phytotherapy for respiratory conditions

Allergic and non-allergic rhinitis

Rhinitis is an inflammation of the lining of the nose characterised by one or more of the following symptoms: nasal congestion, nasal discharge, sneezing and itching. Acute infectious rhinitis (and sinusitis) is usually due to the common cold and the appropriate treatment is described later in this chapter. Chronic infectious rhinitis is treated using the same approach as described later under chronic sinusitis. Allergic rhinitis is triggered by inhaled allergens and may be perennial or seasonal (hayfever). Non-allergic or vasomotor rhinitis has no identified medical cause, although in naturopathic traditions it is understood as being caused or exacerbated by diet. Rhinitis may also be drug-induced, rhinitis medicamentosus, by overuse of nasal sprays containing decongestants.

In phytotherapy for rhinitis, it is important to identify whether or not inhaled allergens are involved, since this determines the approach to treatment. Allergic rhinitis is usually characterised by sneezing, itching, nasal discharge, conjunctivitis and nasal congestion. There will usually be a family history of allergy and secretions are often copious, clear and thin. Diagnosis is confirmed by positive skin prick test or radioallergosorbent test (RAST) to aeroallergens. In contrast, non-allergic rhinitis is mainly characterised by chronic nasal congestion with a scant, thin, whitish discharge. Skin prick tests and RAST are negative, and it usually has an adult onset.

The acute allergic response in rhinitis results from the interaction of an inhaled allergen with a specific IgE antibody on the surface of mast cells and basophils. This leads to the release of histamine and other factors that cause the acute symptoms. In chronic, persistent rhinitis, T cells recruit eosinophils (in a process quite similar to asthma) and this leads to chronic symptoms such as nasal blockage, loss of smell and nasal hyper-reactivity.

Allergens involved in seasonal allergic rhinitis are usually grass pollens, but pollens from other plants including trees may be implicated. In perennial allergic rhinitis, house dust mite, molds, cockroaches and cats are common sources of allergen.

Treatment

The approach suggested for the herbal treatment of rhinitis is to control symptoms and remove causes. Avoidance measures to reduce exposure to aeroallergens should be part of this treatment, such as the standard procedures to reduce levels of dust mite allergens. Staying at high altitudes or by the sea can substantially reduce pollen exposure (sea breezes are low in pollen).

Dietary exclusions should be trialled for both allergic and non-allergic rhinitis. Herbalists believe that diet can create a state of hypersensitivity and catarrh of the mucous membranes that predisposes to rhinitis. The dietary components that contribute to this process do not necessarily give a positive reaction on the RAST or skin prick test. They include dairy products, wheat, salt and refined carbohydrates. Excessive consumption of these should be avoided by sufferers of rhinitis and complete exclusion of one component (e.g. dairy products) should be tried for at least 2 months, or prior to and during the allergy season.

In order for an allergic reaction to occur, an allergen must penetrate deep into the nasal lining. If the mucous membranes are healthy and intact, the allergen will never reach the mast cells to trigger an allergic reaction. This is why traditional herbalists have stressed the importance of healthy upper respiratory mucous membranes in the management of allergic rhinitis and rely on upper respiratory anticatarrhal herbs (which is really just another way of saying herbs that promote a healthy condition of the mucous membranes) as their mainstay of treatment.

Eyebright is often misunderstood in mass-market products and popular literature. Because of the common name it is often promoted to help vision. But this has never been the case. Because of its favourable effect on upper respiratory mucous membranes, the conjunctiva acquires a healthy sheen, hence the ‘eye is bright’. The herb will have this effect if taken orally or applied topically.

Essential aspects of treatment are as follows

• Immune-enhancing herbs such as Echinacea root and Astragalus. This is especially the case for allergic rhinitis

• Antiallergic herbs only in the case of allergic rhinitis, including Albizia, Baical skullcap and Nigella

• Upper respiratory anticatarrhal herbs for both types of rhinitis, including Euphrasia, Hydrastis and Plantago lanceolata

• When treating seasonal allergic rhinitis, treatment must be commenced 6 weeks before the season starts and continued through the season. Any helpful dietary exclusions should also follow this time pattern

• Stress can exacerbate rhinitis and should be treated if it is considered to be a factor with tonic herbs, nervine tonics, sedative herbs and adaptogens as appropriate

• Treatment of rhinitis at a deeper level may involve the use of depuratives (e.g. Galium – clivers), lymphatics (e.g. Phytolacca – poke root) and choleretics and other liver herbs.

Case history

A 30-year-old female patient with chronic persistent rhinitis. Symptoms were worse in the morning with clear nasal discharge and irritated eyes. She was sensitive to house dust mite and had suffered tonsillitis, adenoids and otitis media as a child. She regularly took antihistamines.

Treatment consisted of a dairy-free diet, protective measures against house dust mite and the following herbs:

Echinacea angustifolia root 1:2 30 mL
Picrorrhiza kurroa 1:2 5 mL
Zingiber officinale 1:2 5 mL
Euphrasia officinalis 1:2 25 mL
Scutellaria baicalensis 1:2 20 mL
Albizia lebbek 1:2 20 mL
  total 105 mL

Dose: 8 mL with water twice a day.

Hydrastis 500 mg tablets, one tablet three times a day. After 3 months of herbs, her antihistamine use was greatly reduced and symptoms were very much improved. Note that Picrorrhiza can be replaced by Andrographis if it is not available.

Common cold and influenza

The common cold (acute rhinitis) is a benign viral infection of the upper respiratory tract that usually occurs in the winter months. Viruses commonly involved are rhinovirus, adenovirus, influenza virus and parainfluenza virus. It usually begins with a sore throat, nasal congestion, sneezing with clear discharge and mild fever. After a few days, a mucopurulent discharge occurs due to secondary bacterial infection. A few days of bed rest may be necessary and full recovery usually occurs 7 to 10 days after onset. Complications or sequelae include acute sinusitis, sore throat, tonsillitis and otitis media (covered in this chapter).

In contrast, influenza is often a more severe respiratory infection which can result in loss of life. The main viruses that cause influenza are enveloped viruses known as influenza A and B. These viruses are capable of mutating and new strains constantly appear. Sometimes influenza A virus can exchange a segment of its genetic material with another virus. This produces a new strain of influenza A to which no-one is immune, leading to a worldwide outbreak or pandemic. These have occurred in 1918, 1957, 1968 and 2009. Influenza is also mainly a winter disease. The influenza virus can produce a range of disease, from a mild common cold to fatal pneumonia (especially in the elderly or severely debilitated). True influenza is usually differentiated from other ‘flu-like’ illnesses by its marked systemic illness with high fever, malaise and muscle pain. Bed rest is usually always required.

(For prevention of respiratory infections, see Chapter 8.)

Treatment

The basic treatment approaches for the common cold and influenza are similar. However, in the case of more severe forms of influenza, treatment is more vigorous (e.g. higher or more repeated doses), and the use of St John’s wort (Hypericum perforatum) and garlic (Allium sativum) as putative antiviral agents is included.

Essential aspects of treatment are as follows:

• Diaphoretics and heating remedies to manage and improve febrile responses. For the most direct agents, circulatory stimulants Zingiber (ginger, especially fresh grated) and cinnamon taken in hot water can dramatically improve mucosal symptoms and fend off the sensation of cold. For more gentle but sustained effects, especially in children, hot teas of Mentha piperita (peppermint), Eupatorium perfoliatum (boneset), Nepeta cataria (catmint), Achillea (yarrow), Tilia (lime flowers) and Sambucus (elderflower) are well-established diaphoretic approaches, which in the context of a cold can exert surprisingly different effects than when consumed at other times. Asclepias tuberosa (pleurisy root) is indicated if there are pulmonary or bronchial complications. Allium sativum (garlic, taken raw) may also be useful as a general and warming defensive agent

• Immune-enhancing herbs such as Echinacea root and Andrographis to help support the body’s fight against the virus. Andrographis is particularly suited to acute respiratory infections, whereas the data for Echinacea root is mixed. Note that Astragalus and tonics such as Panax ginseng are contraindicated in the acute stage of infection. Pelargonium sidoides and elderberry also have positive clinical data and may support immunity and have other relevant activities

• Anticatarrhal herbs for upper respiratory catarrh, especially Euphrasia (eyebright), Sambucus (elderflower) and Hydrastis (golden seal). Traditionally, Hydrastis was said to be contraindicated in the acute stage of infection, so its use may be best in the later stages of the secondary bacterial infection

• Hypericum (St John’s wort) as an antiviral treatment for influenza.

Since these are acute disorders, dosages should be high and often.

Case histories

The following case history demonstrates the value of immune-enhancing therapy as an early intervention. John aged 42 was about to fly from Brisbane to London (24 h) and had just caught a cold. He was concerned about the adverse effect of flying on his condition. He was prescribed Echinacea angustifolia root tablets 500 mg and was advised to take two tablets every hour, if possible. By the time John arrived in London his cold was almost gone. He continued to take two Echinacea root tablets every few hours the next day and the cold did not reappear.

The next case history illustrates a more complete approach to treating the common cold. Anne, aged 38, presented with the early stages of a cold including a clear discharge and fever. She was treated with the following formula and recovered quickly with only mild symptoms:

Echinacea angustifolia root 1:2 40 mL
Picrorrhiza kurroa 1:2 10 mL
Zingiber officinale 1:2 5 mL
Achillea millefolium 1:2 25 mL
Sambucus nigra flower 1:2 20 mL
  total 100 mL

Dose: 5 mL with 40 mL hot water five to six times daily.

Treatment was also supplemented with regular intake of peppermint infusions and up to six allicin-releasing garlic (Allium sativum) tablets (5000 mg fresh weight equivalent) a day. Rest was also advised.

Note: for the treatment of influenza the above regime could be followed but the elderflower could be replaced by a high hypericin extract of St John’s wort which has antiviral activity. Where Picrorrhiza is referred to it can be replaced with appropriate doses of Andrographis.

Acute and chronic bacterial sinusitis

With sinusitis, drainage of the sinuses is partially blocked, usually by congestion and mucosal oedema. This results in stasis that allows a bacterial infection to take hold. Pain is caused by either negative pressure (due to absorption of gases by the vasculature) or the positive pressure of mucosal congestion.

Factors involved in the aetiology of chronic sinusitis include pollution, occupational dust exposure, tobacco smoke, adenoids, allergy (especially in children), rhinitis, cold and damp weather, dental problems, trauma and flying. A deviated nasal septum or other structural causes may be present. Phytotherapists also believe that dietary factors can cause excessive mucus discharge, which may cause and sustain the disease. Particularly implicated are dairy products, salt and wheat. Stasis and congestion may be aggravated if the patient has inadequate fluid intake.

Treatment

The treatment approaches for acute and chronic bacterial sinusitis are similar. For acute sinusitis the dose should be higher and given more frequently and treatment may need to be supplemented with diaphoretics etc., as for acute rhinitis, if fever is present. Key aspects are:

• supporting the immune system in its fight against the bacteria involved using immune-enhancing herbs such as Echinacea and Andrographis

• anticatarrhal herbs (e.g. Euphrasia) to help clear the stasis

• mucolytic herbs to help clear the stasis, such as Allium sativum (garlic) and Armoracia (horseradish)

• particularly indicated is Hydrastis (golden seal), which has antimicrobial and anticatarrhal properties and is a mucous membrane trophorestorative. Regularly chewing a Hydrastis tablet can be very beneficial, but they are exceedingly bitter

• A steam inhalation containing antimicrobial and anti-inflammatory essential oils, such as tea tree, pine or aniseed oils, or chamomile flowers, may be useful.

For chronic sinusitis only

• Patients with chronic sinusitis should avoid antihistamines and steroid-based decongestant drugs as these will weaken immunity in the region further.

• Chronic sinusitis may represent a vicarious elimination and this can be additionally treated with depuratives such as Galium (cleavers), and lymphatics such as Phytolacca (poke root)

• Exposure to the environmental factors listed above should be reduced and a dairy-free, low-salt diet should be trialled for at least 3 months. Antiallergic herbs may also be relevant

• The sinuses are relatively inaccessible regions of the body and once a chronic infection has taken hold it can be difficult to eradicate.

The following topical treatment can be beneficial:

Capsicum annuum 1:3 20 mL
Lobelia inflata 1:8 20 mL
Hydrastis canadensis 1:3 20 mL
Commiphora molmol 1:5 20 mL
Myrica cerifera 1:2 20 mL
  TOTAL 100 mL

Work over the affected sinuses for 10 minutes once to twice a day. Keep away from the eyes. Use a glove or wash hands after using.

The Capsicum and Myrica act as decongestants, the myrrh is antiseptic and Lobelia assists penetration. The properties of Hydrastis are given above. If Lobelia is unavailable, substitute with a saponin-containing herb such as Bupleurum or Aesculus (horsechestnut).

Case history

A male patient aged 36 presented with chronic sinusitis that followed a bout of the common cold. There was a history of allergic rhinitis with chronic use of antihistamines and nasal steroids. Antibiotics had failed to resolve the condition, which had been present for 4 years. The patient had a high dairy intake and had been a cigarette smoker. Treatment consisted of the following:

Echinacea angustifolia root 1:2 40 mL
Euphrasia officinalis 1:2 30 mL
Hydrastis canadensis 1:3 25 mL
Phytolacca decandra 1:5 5 mL
  total 100 mL

Dose: 5 mL with water three times daily

In addition, allicin-releasing garlic (Allium sativum) tablets (5000 mg fresh weight equivalent) three per day and Picrorrhiza 500 mg tablets, two per day, were prescribed. The patient was placed on a dairy-free and low-salt diet and advised not to use antihistamines and steroid decongestant drugs. The above sinus rub was also prescribed.

After a period of 6 months of treatment, symptoms were considerably improved.

Note that the Picrorrhiza can be substituted by Andrographis and the E. angustifolia root by a mixture of E. purpurea and E. angustifolia roots.

Chronic tonsillitis and chronic sore throat

Chronic sore throat may be a symptom of other disorders, such as sinusitis. However, it may exist in its own right as a chronic bacterial infection in a patient with or without tonsils. The organism usually responsible is a group A Streptococcus.

The approaches to the herbal treatment of chronic tonsillitis and chronic sore throat are similar. The main aspects of treatment are as follows:

• Immune-enhancing herbs. Being a chronic condition, Astragalus may be used as well as Echinacea root and Andrographis. Echinacea root is best taken as a liquid to obtain a local effect on the throat

• Lymphatic and depurative herbs are particularly indicated in tonsillitis and include Phytolacca, Echinacea root, Galium and Arctium lappa (burdock)

• Anticatarrhal herbs, particularly eyebright and golden seal

• A local treatment such as a throat spray or lozenge using herbs such as:

image Glycyrrhiza (licorice) – soothing, anti-inflammatory, topically antiviral
image Salvia (sage) – astringent and antiseptic to the mucous membranes
image Propolis – antiseptic, healing and anaesthetic
image Kava – local anaesthetic to provide a soothing effect (or clove essential oil)
image Echinacea root – immune-enhancing, anti-inflammatory
image Capsicum – stimulant, antiseptic
image Hydrastis (golden seal) – antiseptic, mucous membrane trophorestorative
image Althaea (marshmallow root) – demulcent
image Myrrh – vulnerary and antiseptic, induces local leucocytosis

• A dairy-free diet rich in fruit and vegetables should be observed.

Example liquid formula

Echinacea purpurea/angustifolia root 1:2 40 mL
Euphrasia officinalis 1:2 25 mL
Phytolacca decandra 1:5 5 mL
Salvia fructicosa 1:2 15 mL
Hydrastis canadensis 1:3 25 mL
  total 110 mL

Dose: 8 mL with water twice a day. Ideally gargle medicine briefly before swallowing.

Case history

A male patient aged 65 complained of a chronic sore throat that had been present for years. Other conditions were also being treated, but for the sore throat he was prescribed:

Echinacea angustifolia root 1:2 5 mL once a day with water

A gargle consisting of:

Echinacea angustifolia root 1:2 40 mL
Propolis 1:5 30 mL
Salvia officinalis 1:2 30 mL
  total 100 mL

Dose: 2 mL in 10 mL water as a gargle on the affected area of the throat twice a day. Swallow after use.

After 8 weeks the sore throat was considerably improved and with continuing treatment it became a minor trouble.

Otitis media

Inflammation of the middle ear, or otitis media, can be divided into suppurative or acute otitis media (AOM), and inflammation accompanied by effusion, termed non-suppurative or secretory otitis media or otitis media with effusion (OME). Viral upper respiratory tract infection is most commonly associated with the onset of AOM, although the major infection present is bacterial. Symptoms can include pain, purulent discharge from the ear, hearing loss, vertigo, tinnitus and fever. Examination will demonstrate a red, dull and bulging or perforated ear drum.

Recurrent AOM is common, affecting between 10% and 20% of children up to 12 months of age.26 Young children have immature immunity and short and poorly functional Eustachian tubes (the latter results in poor middle ear ventilation). Chronic otitis media with discharge from the ear can result from ineffectively treated acute or recurrent otitis media. The infection is clearly bacterial.

OME is an enigmatic disorder that also usually occurs in children. Examination of the ear drum shows that it is retracted (‘sucked in’) and there is fluid in the middle ear cavity that can lead to conductive hearing loss. Allergy, nasal infection and chronic sinus infection may be involved and it is associated with increased frequency of respiratory infections. Medical treatment can involve the use of grommets to drain the middle ear cavity. The overuse of antibiotics is probably ill advised, although bacterial infection may play a role in some patients with this disorder.

Treatment

The treatments of acute and chronic otitis media are similar to the treatments of acute and chronic sinusitis respectively (with the exclusion of the topical treatment).

OME should be regarded as an allergic disorder, as well as possibly a vicarious elimination. A dairy-free, low-salt diet should be tried or otherwise a full elimination diet. However, the presence of microorganisms that contribute to the inflammation or the malfunction of the Eustachian tube should also be considered. If adenoids are implicated, then the OME should be treated similarly to tonsillitis. The following herbs are emphasised during OME treatment:

• Antiallergic and decongestant herbs such as Albizia, Scutellaria baicalensis and Nigella

• Upper respiratory anticatarrhal herbs such as Euphrasia, Solidago, Hydrastis, Plantago lanceolata and Glechoma hederacea

• Depurative and lymphatic herbs such as Galium (clivers) and Phytolacca

• Immune-enhancing herbs, particularly Echinacea root and Astragalus, to correct the presence of allergy and possibly infection

• Chewing on a Hydrastis tablet (difficult for children because of its bitterness) will accentuate its mucous membrane trophorestorative and antibacterial effects on the upper respiratory tract.

Example liquid formula for AOM

Echinacea purpurea/angustifolia root 1:2 35 mL
Sambucus nigra flower 1:2 25 mL
Pelargonium sidoides 1:5 20 mL
Euphrasia officinalis 1:2 25 mL
  total 105 mL

Adult dose is 5 mL with warm water five to six times a day for acute AOM and 5 mL three times a day as a preventative for recurrent AOM. Children’s doses should be calculated from the application of an appropriate dosage rule.

Acute bronchitis

Acute bronchitis is an acute inflammation of the trachea and bronchi. It commonly follows the common cold, influenza, measles or whooping cough. Patients with chronic bronchitis are particularly prone to develop episodes of acute bacterial bronchitis (where their sputum turns from grey or white to yellow or green). Other factors that can predispose to this kind of bacterial infection include cold, damp, dust and cigarette smoking.

Initially there is an irritating, unproductive cough that eventually progresses over a few days to copious, mucopurulent sputum. Infection usually starts in the trachea and progresses to the bronchi and with this spread there is a general febrile disturbance with temperatures of 38°C to 39°C. Gradual recovery should occur over the next 4 to 8 days. However, it may progress to bronchiolitis or bronchopneumonia.

Treatment

Being an acute disorder, it is important to give frequent doses of herbs and, if possible, to follow the progression of the infection, adapting the treatment to the various stages:

• Antiseptic herbs such as Inula helenium, Thymus vulgaris and Allium sativum (garlic) should be prescribed throughout the course of the infection and preferably should be continued for 1 week into recovery to prevent relapse

• During the dry, unproductive cough phase, demulcents such as Althaea glycetract should be prescribed. This combines well with a small quantity of Glycyrrhiza (licorice) (see under Chronic obstructive pulmonary disease below)

• Diaphoretic herbs are indicated during the febrile phase, particularly Asclepias tuberosa (pleurisy root), which is almost a specific for acute lower respiratory tract infections. It is often combined with Zingiber (ginger) to enhance its effectiveness. Other diaphoretics such as Tilia and Achillea can also be prescribed

• Expectorant herbs, which include Inula helenium, Thymus vulgaris, Polygala and other saponin-containing herbs, Foeniculum (fennel), Pimpinella (aniseed) and Marrubium (white horehound) can be prescribed throughout the course of the disorder

• Anticatarrhal herbs, especially Verbascum, Plantago lanceolata and Hydrastis, may be indicated when the sputum is particularly copious or if the productive cough lingers beyond the acute stage

• Antitussive herbs should be used to help the cough, especially at night, and Prunus serotina (wild cherry) is particularly indicated if tracheitis predominates.

Example liquid formula

Echinacea purpurea/angustifolia root 1:2 25 mL
Asclepias tuberosa 1:2 20 mL
Zingiber officinale 1:2 5 mL
Inula helenium 1:2 20 mL
Glycyrrhiza glabra 1:1 15 mL
Foeniculum vulgare 1:2 20 mL
  total 105 mL

Dose: 5 mL with 40 mL warm water five to six times a day.

Whooping cough

Whooping cough or pertussis is a highly infectious disease caused by Bordetella pertussis. About 90% of cases occur in children under 5 years.

The first stage consists of respiratory infection lasting about 1 week during which conjunctivitis, rhinitis and an unproductive cough are present. Diagnosis is difficult at this stage, since it resembles other respiratory infections.

The coughing stage follows and is characterised by severe bouts of coughing. Each paroxysm consists of many short sharp coughs, gathering in speed and duration and ending in a deep inspiration when the characteristic whoop may be heard. The paroxysms can end with vomiting. This stage can last from one to several weeks. The sputum is particularly tenacious and difficult to expectorate.

Treatment

The treatment approach is similar to acute bronchitis but different aspects of the treatment are emphasised:

• Immune-enhancing herbs such as Echinacea and Andrographis and respiratory antiseptic herbs such as Inula helenium, Thymus vulgaris and Allium sativum (garlic) should be prescribed throughout to treat the infection and prevent complications

• In the coughing stage, expectorant herbs such as Inula helenium, Thymus vulgaris, Polygala, Glycyrrhiza (licorice) and other saponin-containing herbs, Foeniculum (fennel), Pimpinella (aniseed) and Marrubium (white horehound) should be emphasised to loosen the tenacious sputum

• Also, antitussive and demulcent herbs are required to dampen and soothe the cough reflex. If vomiting is occurring, these should be extended by gastrointestinal spasmolytics such as Viburnum opulus. (See also the marshmallow-licorice formulation below under Chronic obstructive pulmonary disease)

• Respiratory spasmolytics with expectorant activity, such as Grindelia and Inula helenium, should also be emphasised in the coughing stage. A combination of Inula, Glycyrrhiza and Lobelia is worth trying for the most severe symptoms

• Mucolytic herbs such as Allium sativum and Armoracia may also be required to help loosen the tenacious sputum.